| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 CLGN ENPP1 ENPP2 ENPP3 DGKB CDH23 PKD1L2 DUOX1 FAT1 HMCN2 EHD1 FER1L5 AMELX FAT3 PCLO PCDH11Y HMCN1 DLL3 LRP2 CDH7 CDH8 PADI3 | 1.38e-05 | 749 | 225 | 23 | GO:0005509 |
| GeneOntologyMolecularFunction | phosphodiesterase I activity | 1.39e-05 | 5 | 225 | 3 | GO:0004528 | |
| GeneOntologyMolecularFunction | translation activator activity | 1.94e-05 | 15 | 225 | 4 | GO:0008494 | |
| GeneOntologyMolecularFunction | dinucleotide phosphatase activity | 1.13e-04 | 9 | 225 | 3 | GO:0004551 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | OBSCN CDH23 ITGA7 FAP MFGE8 PVR EHD1 HSPA1A VSIG10L2 FLNA FLNB FN1 NRCAM ADAMTS8 YWHAB WASF2 CDH7 CDH8 | 1.61e-04 | 599 | 225 | 18 | GO:0050839 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.91e-04 | 188 | 225 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | denatured protein binding | 3.76e-04 | 3 | 225 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATP6V1A MYH3 ABCA12 ENPP1 ENPP2 ENPP3 RHOU DDX46 ABCD4 ENPP5 ASCC3 HSPA1A DNAH5 HSPA1B GNL1 RAC1 RAC2 RAC3 DHX57 ABCB9 DNAH11 | 5.51e-04 | 839 | 225 | 21 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATP6V1A MYH3 ABCA12 ENPP1 ENPP2 ENPP3 RHOU DDX46 ABCD4 ENPP5 ASCC3 HSPA1A DNAH5 HSPA1B GNL1 RAC1 RAC2 RAC3 DHX57 ABCB9 DNAH11 | 5.59e-04 | 840 | 225 | 21 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATP6V1A MYH3 ABCA12 ENPP1 ENPP2 ENPP3 RHOU DDX46 ABCD4 ENPP5 ASCC3 HSPA1A DNAH5 HSPA1B GNL1 RAC1 RAC2 RAC3 DHX57 ABCB9 DNAH11 | 5.59e-04 | 840 | 225 | 21 | GO:0016818 |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 6.25e-04 | 35 | 225 | 4 | GO:0043325 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | MAP1A TAB2 PTPN22 DAZ1 WNK1 LRIG2 WASH6P MET SECISBP2 DAZ3 DAZ2 RBM38 FLNA DAZ4 CTSA DICER1 LEPR TENT5B TAB3 STK38L SORL1 | 5.56e-09 | 418 | 222 | 21 | GO:0009895 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 PSG11 CDH23 FAT1 HMCN2 PVR SDK1 NRCAM FAT3 PCDH11Y HMCN1 CDH7 CDH8 | 1.26e-07 | 187 | 222 | 13 | GO:0007156 |
| GeneOntologyBiologicalProcess | female meiosis II | 1.93e-07 | 6 | 222 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 1.93e-07 | 6 | 222 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 1.93e-07 | 6 | 222 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | negative regulation of autophagy | 3.47e-06 | 112 | 222 | 9 | GO:0010507 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 4.32e-06 | 115 | 222 | 9 | GO:1903312 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 4.47e-06 | 87 | 222 | 8 | GO:1902373 | |
| GeneOntologyBiologicalProcess | negative regulation of inclusion body assembly | 6.04e-06 | 12 | 222 | 4 | GO:0090084 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 PSG11 CDH23 WNK1 FAT1 HMCN2 PVR SDK1 NRCAM FAT3 PCDH11Y HMCN1 CDH7 CDH8 | 8.09e-06 | 313 | 222 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | regulation of catabolic process | TMEM67 ATP6V1A MAP1A TAB2 PTPN22 DAZ1 RB1CC1 WNK1 LRIG2 WASH6P MET FAP SECISBP2 DAZ3 DAZ2 HSPA1A HSPA1B RBM38 FLNA TRIB2 DAZ4 CTSA DICER1 LEPR TENT5B TAB3 SLC2A6 LRP2 STK38L TRIB1 SORL1 | 1.26e-05 | 1252 | 222 | 31 | GO:0009894 |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 1.36e-05 | 101 | 222 | 8 | GO:1902369 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 1.87e-05 | 31 | 222 | 5 | GO:0070935 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 1.93e-05 | 77 | 222 | 7 | GO:0048255 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | MAP1A ENPP1 ENPP2 CDH23 ITGA7 RHOU KIAA0319 MET FAT1 HMCN2 RAC1 RAC3 PLXNA3 FLNA FLNB CPNE9 FN1 NRCAM FAT3 CREB1 DICER1 THOC5 CSF1R WASF2 LRP2 PRKDC CDH7 CDH8 EPHA4 | 3.52e-05 | 1194 | 222 | 29 | GO:0000902 |
| GeneOntologyBiologicalProcess | myeloid cell differentiation | ENPP1 PSG11 INPP4B RABGAP1L HSPA1A HSPA1B RAC1 RAC2 FLNA IRF8 CREB1 THOC5 CSF1R SH3PXD2A WASF2 PRKDC TRIB1 IL5 | 3.67e-05 | 558 | 222 | 18 | GO:0030099 |
| GeneOntologyBiologicalProcess | RNA stabilization | 4.62e-05 | 88 | 222 | 7 | GO:0043489 | |
| GeneOntologyBiologicalProcess | nucleotide-binding oligomerization domain containing 2 signaling pathway | 5.53e-05 | 20 | 222 | 4 | GO:0070431 | |
| GeneOntologyBiologicalProcess | regulation of inclusion body assembly | 6.77e-05 | 21 | 222 | 4 | GO:0090083 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | MAP1A ENPP1 PSG11 CDH23 RAC1 RAC2 RAC3 COL9A1 CREB1 CD7 CSF1R ATF1 INAVA | 7.19e-05 | 334 | 222 | 13 | GO:0060249 |
| GeneOntologyBiologicalProcess | tissue homeostasis | MAP1A ENPP1 PSG11 CDH23 RAC1 RAC2 RAC3 COL9A1 CREB1 CD7 CSF1R ATF1 INAVA | 7.19e-05 | 334 | 222 | 13 | GO:0001894 |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | ENPP2 ITGA7 RHOU MET RAC1 RAC3 PLXNA3 CPNE9 FN1 CSF1R PRKDC EPHA4 | 1.12e-04 | 302 | 222 | 12 | GO:0022604 |
| GeneOntologyBiologicalProcess | regulation of eosinophil differentiation | 1.15e-04 | 2 | 222 | 2 | GO:0045643 | |
| GeneOntologyBiologicalProcess | positive regulation of eosinophil differentiation | 1.15e-04 | 2 | 222 | 2 | GO:0045645 | |
| GeneOntologyBiologicalProcess | inhibition of non-skeletal tissue mineralization | 1.40e-04 | 10 | 222 | 3 | GO:0140928 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 1.47e-04 | 47 | 222 | 5 | GO:0001556 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 1.62e-04 | 26 | 222 | 4 | GO:0045836 | |
| GeneOntologyBiologicalProcess | regulation of protein ubiquitination | HDAC8 PTPN22 WNK1 WASH6P HSPA1A HSPA1B TRIB2 INAVA TOPORS TRIB1 | 1.77e-04 | 226 | 222 | 10 | GO:0031396 |
| GeneOntologyBiologicalProcess | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.90e-04 | 11 | 222 | 3 | GO:0070432 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | CYP1A1 TMEM67 MBTPS1 CENPF MAP3K20 OR1A2 DAZ1 STOX1 WNK1 UBE2U MET FAP HOXD10 PIM1 SPATA22 DAZ3 DAZ2 HSPA1A HSPA1B RBM38 DAZ4 DICER1 TENT5B MADD RNF167 CSF1R PRKDC PHF10 | 2.07e-04 | 1256 | 222 | 28 | GO:0051726 |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 2.38e-04 | 52 | 222 | 5 | GO:0007143 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to cell surface | 2.51e-04 | 29 | 222 | 4 | GO:2000010 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 2.51e-04 | 29 | 222 | 4 | GO:0045948 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DCHS2 ABCA12 PSG11 CDH23 PTPN22 ITGA7 WNK1 SLC7A11 FBXO38 FAT1 HMCN2 PVR SDK1 VSIG10L2 RAC2 FLNA NRCAM FAT3 PCDH11Y PDIA3 HMCN1 FUT9 PHF10 CDH7 CDH8 | 2.53e-04 | 1077 | 222 | 25 | GO:0098609 |
| GeneOntologyBiologicalProcess | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 2.87e-04 | 30 | 222 | 4 | GO:0035872 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | MYH3 ENPP1 PSG11 MATR3 OBSCN EXT2 WNK1 TXNRD1 FAP MFGE8 PNPLA6 PIM1 EHD1 SDK1 PLXNA3 AMELX FLNA FLNC COL12A1 FN1 FAT3 DICER1 RBM20 LEPR CSF1R SH3PXD2A WASF2 DLL3 TXNRD3 LRP2 PRKDC | 2.89e-04 | 1483 | 222 | 31 | GO:0048646 |
| GeneOntologyBiologicalProcess | regulation of platelet formation | 3.44e-04 | 3 | 222 | 2 | GO:1905219 | |
| GeneOntologyBiologicalProcess | inclusion body assembly | 4.18e-04 | 33 | 222 | 4 | GO:0070841 | |
| GeneOntologyBiologicalProcess | bone remodeling | 4.56e-04 | 127 | 222 | 7 | GO:0046849 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | TMEM67 ENPP2 PSG11 TAB2 PTPN22 DAZ1 STOX1 RB1CC1 MET PIM1 SECISBP2 DAZ3 DAZ2 HSPA1A HSPA1B RAC1 TRIB2 DAZ4 LEPR TENT5B CSF1R LRP2 INAVA PRKDC TOPORS TRIB1 IL5 SOAT1 EPHA4 SORL1 | 4.74e-04 | 1458 | 222 | 30 | GO:0051247 |
| GeneOntologyCellularComponent | anchoring junction | MYH2 DCHS2 MYLK PSG11 OBSCN ITGA7 RHOU FOCAD FAP FCHSD2 FAT1 UBA1 PVR HSPA1A HSPA1B VSIG10L2 RAC1 RAC2 FLNA FLNB FLNC YWHAB PDIA3 HMCN1 SH3PXD2A WASF2 CDH7 CDH8 EPHA4 | 9.78e-07 | 976 | 228 | 29 | GO:0070161 |
| GeneOntologyCellularComponent | vacuolar membrane | ATP6V1A ENPP1 TAB2 RB1CC1 DDOST UBA1 CLCN4 PIGR ABCD4 SLC36A4 CTSA YWHAB RNF167 ABCB9 SLC2A6 ATP6V0A4 LRP2 WDFY3 | 1.24e-05 | 507 | 228 | 18 | GO:0005774 |
| GeneOntologyCellularComponent | cell-substrate junction | ITGA7 RHOU FOCAD FAP FAT1 PVR HSPA1A HSPA1B RAC1 RAC2 FLNA FLNB FLNC YWHAB PDIA3 HMCN1 | 3.11e-05 | 443 | 228 | 16 | GO:0030055 |
| GeneOntologyCellularComponent | NADPH oxidase complex | 3.74e-05 | 18 | 228 | 4 | GO:0043020 | |
| GeneOntologyCellularComponent | endosome | ATP6V1A TAB2 CREG1 ZP2 RHOU KIAA0319 WASH6P FCHSD2 UBA1 CLCN4 PIGR RABGAP1L EHD1 RAC1 MON1A PDIA3 TAB3 IFNAR1 RNF167 ABCB9 CD22 WASF2 ATP6V0A4 DLL3 LRP2 CTSE EPHA4 SORL1 | 7.66e-05 | 1167 | 228 | 28 | GO:0005768 |
| GeneOntologyCellularComponent | lysosomal membrane | ATP6V1A ENPP1 TAB2 DDOST UBA1 CLCN4 PIGR ABCD4 SLC36A4 CTSA RNF167 ABCB9 SLC2A6 ATP6V0A4 LRP2 | 1.79e-04 | 462 | 228 | 15 | GO:0005765 |
| GeneOntologyCellularComponent | lytic vacuole membrane | ATP6V1A ENPP1 TAB2 DDOST UBA1 CLCN4 PIGR ABCD4 SLC36A4 CTSA RNF167 ABCB9 SLC2A6 ATP6V0A4 LRP2 | 1.79e-04 | 462 | 228 | 15 | GO:0098852 |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.30e-04 | 112 | 228 | 7 | GO:0055038 | |
| GeneOntologyCellularComponent | apical part of cell | ATP6V1A PSG11 ENPP3 CDH23 IFIT5 SLC7A11 FAP DUOX1 FAT1 HSPA1A HSPA1B MGAM FN1 PDIA3 SLC17A1 ATP6V0A4 LRP2 | 2.86e-04 | 592 | 228 | 17 | GO:0045177 |
| GeneOntologyCellularComponent | focal adhesion | RHOU FOCAD FAP FAT1 PVR HSPA1A HSPA1B RAC1 RAC2 FLNA FLNB FLNC YWHAB PDIA3 | 2.92e-04 | 431 | 228 | 14 | GO:0005925 |
| GeneOntologyCellularComponent | endosome membrane | ATP6V1A TAB2 RHOU KIAA0319 WASH6P UBA1 CLCN4 PIGR EHD1 RAC1 PDIA3 TAB3 RNF167 ATP6V0A4 DLL3 EPHA4 SORL1 | 3.47e-04 | 602 | 228 | 17 | GO:0010008 |
| GeneOntologyCellularComponent | ATF4-CREB1 transcription factor complex | 7.00e-04 | 4 | 228 | 2 | GO:1990589 | |
| GeneOntologyCellularComponent | recycling endosome | 7.69e-04 | 222 | 228 | 9 | GO:0055037 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 7.94e-04 | 223 | 228 | 9 | GO:0098862 | |
| GeneOntologyCellularComponent | vacuole | ATP6V1A ENPP1 TAB2 RB1CC1 CREG1 DDOST WASH6P UBA1 CLCN4 PIGR ABCD4 SLC36A4 CTSA YWHAB IFNAR1 RNF167 ABCB9 SLC2A6 ATP6V0A4 LRP2 WDFY3 | 1.07e-03 | 913 | 228 | 21 | GO:0005773 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | TMEM67 ATP6V1A ABCA12 TAB2 RHOU DDOST KIAA0319 WASH6P MFGE8 UBA1 CLCN4 PIGR EHD1 FER1L5 SVOP RAC1 RAC2 MGAM PDIA3 TAB3 RNF167 ATP6V0A4 DLL3 LRP2 EPHA4 AHNAK2 SORL1 | 1.07e-03 | 1307 | 228 | 27 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | TMEM67 ATP6V1A ABCA12 TAB2 RHOU DDOST KIAA0319 WASH6P MFGE8 UBA1 CLCN4 PIGR EHD1 FER1L5 SVOP RAC1 RAC2 MGAM PDIA3 TAB3 RNF167 ATP6V0A4 DLL3 LRP2 EPHA4 AHNAK2 SORL1 | 1.31e-03 | 1325 | 228 | 27 | GO:0012506 |
| GeneOntologyCellularComponent | 9+0 motile cilium | 1.73e-03 | 6 | 228 | 2 | GO:0097728 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 1.73e-03 | 6 | 228 | 2 | GO:0005593 | |
| GeneOntologyCellularComponent | muscle tendon junction | 1.73e-03 | 6 | 228 | 2 | GO:0005927 | |
| GeneOntologyCellularComponent | cell-cell junction | MYH2 DCHS2 MYLK PSG11 OBSCN FAT1 UBA1 PVR VSIG10L2 FLNA HMCN1 WASF2 CDH7 CDH8 EPHA4 | 2.20e-03 | 591 | 228 | 15 | GO:0005911 |
| MousePheno | abnormal knee morphology | 9.59e-06 | 23 | 181 | 5 | MP:0030881 | |
| MousePheno | increased CD8-positive, alpha-beta memory T cell number | 1.28e-05 | 84 | 181 | 8 | MP:0010838 | |
| MousePheno | abnormal patella morphology | 4.38e-05 | 16 | 181 | 4 | MP:0005353 | |
| MousePheno | abnormal CD8-positive, alpha-beta memory T cell number | 6.48e-05 | 105 | 181 | 8 | MP:0012774 | |
| MousePheno | abnormal CD8-positive, alpha-beta memory T cell morphology | 6.48e-05 | 105 | 181 | 8 | MP:0010837 | |
| MousePheno | situs inversus with levocardia | 7.19e-05 | 7 | 181 | 3 | MP:0011253 | |
| MousePheno | increased IgE level | 9.85e-05 | 83 | 181 | 7 | MP:0002497 | |
| MousePheno | abnormal IgE level | 1.01e-04 | 143 | 181 | 9 | MP:0020173 | |
| MousePheno | increased effector memory CD8-positive, alpha-beta T cell number | 1.11e-04 | 59 | 181 | 6 | MP:0010850 | |
| MousePheno | biventricular, ambiguous atrioventricular connection | 1.67e-04 | 2 | 181 | 2 | MP:0011511 | |
| MousePheno | increased effector memory CD4-positive, alpha-beta T cell number | 1.77e-04 | 41 | 181 | 5 | MP:0010844 | |
| MousePheno | interrupted aortic arch | 1.77e-04 | 41 | 181 | 5 | MP:0004157 | |
| MousePheno | abnormal artery morphology | TMEM67 ENPP1 MATR3 WNK1 PNPLA6 PITX1 DNAH5 FLNA FLNB FN1 XPNPEP1 LEPR SH3PXD2A WASF2 LRP2 DNAH11 | 1.95e-04 | 440 | 181 | 16 | MP:0002191 |
| MousePheno | increased memory T cell number | 2.08e-04 | 124 | 181 | 8 | MP:0008049 | |
| MousePheno | interrupted aorta | 2.22e-04 | 43 | 181 | 5 | MP:0010544 | |
| MousePheno | increased CD8-positive, alpha-beta T cell number | PTPN22 NUP210 RAC2 TRIB2 TMPRSS6 DICER1 LEPR IFNAR1 CD22 PRKDC | 2.27e-04 | 195 | 181 | 10 | MP:0008078 |
| Domain | Ig-like_fold | MYLK PSG11 OBSCN KIAA0319 LRIG2 IGSF10 MET HMCN2 PIGR PVR SDK1 PLXNA3 FLNA FLNB FLNC COL12A1 FN1 NRCAM LEPR IFNAR1 CD7 CSF1R HMCN1 CD22 EPHA4 SORL1 | 3.60e-07 | 706 | 223 | 26 | IPR013783 |
| Domain | E-NPP | 6.73e-07 | 7 | 223 | 4 | IPR024873 | |
| Domain | - | MYLK PSG11 OBSCN LRIG2 IGSF10 MET PIGR PVR SDK1 PLXNA3 FLNA FLNB FLNC COL12A1 FN1 NRCAM LEPR IFNAR1 CD7 CSF1R HMCN1 CD22 EPHA4 SORL1 | 1.42e-06 | 663 | 223 | 24 | 2.60.40.10 |
| Domain | FN3 | MYLK OBSCN KIAA0319 SDK1 FLNC COL12A1 FN1 NRCAM LEPR IFNAR1 EPHA4 SORL1 | 2.37e-06 | 185 | 223 | 12 | SM00060 |
| Domain | Phosphodiest/P_Trfase | 3.93e-06 | 10 | 223 | 4 | IPR002591 | |
| Domain | Phosphodiest | 3.93e-06 | 10 | 223 | 4 | PF01663 | |
| Domain | FN3_dom | MYLK OBSCN KIAA0319 SDK1 FLNC COL12A1 FN1 NRCAM LEPR IFNAR1 EPHA4 SORL1 | 8.33e-06 | 209 | 223 | 12 | IPR003961 |
| Domain | Cadherin | 1.22e-05 | 118 | 223 | 9 | IPR002126 | |
| Domain | DNA/RNA_non-sp_Endonuclease | 3.27e-05 | 6 | 223 | 3 | IPR001604 | |
| Domain | - | 3.27e-05 | 6 | 223 | 3 | 3.40.570.10 | |
| Domain | Endonuclease_NS | 3.27e-05 | 6 | 223 | 3 | PF01223 | |
| Domain | Extracellular_endonuc_su_A | 3.27e-05 | 6 | 223 | 3 | IPR020821 | |
| Domain | NUC | 3.27e-05 | 6 | 223 | 3 | SM00477 | |
| Domain | Endonuclease_NS | 3.27e-05 | 6 | 223 | 3 | SM00892 | |
| Domain | RHO | 8.25e-05 | 20 | 223 | 4 | PS51420 | |
| Domain | Somatomedin_B | 9.00e-05 | 8 | 223 | 3 | PF01033 | |
| Domain | IGc2 | MYLK PSG11 OBSCN LRIG2 IGSF10 HMCN2 SDK1 NRCAM CSF1R HMCN1 CD22 | 1.27e-04 | 235 | 223 | 11 | SM00408 |
| Domain | Ig_sub2 | MYLK PSG11 OBSCN LRIG2 IGSF10 HMCN2 SDK1 NRCAM CSF1R HMCN1 CD22 | 1.27e-04 | 235 | 223 | 11 | IPR003598 |
| Domain | SO | 1.34e-04 | 9 | 223 | 3 | SM00201 | |
| Domain | Creatinase_N | 1.42e-04 | 2 | 223 | 2 | IPR000587 | |
| Domain | Peptidase_M24_C | 1.42e-04 | 2 | 223 | 2 | PF16188 | |
| Domain | Creatinase_N | 1.42e-04 | 2 | 223 | 2 | PF01321 | |
| Domain | Storkhead-box_winged-helix | 1.42e-04 | 2 | 223 | 2 | IPR019391 | |
| Domain | Stork_head | 1.42e-04 | 2 | 223 | 2 | PF10264 | |
| Domain | Pept_M24B | 1.42e-04 | 2 | 223 | 2 | IPR033740 | |
| Domain | Peptidase_M24_C | 1.42e-04 | 2 | 223 | 2 | IPR032416 | |
| Domain | - | 1.43e-04 | 95 | 223 | 7 | 2.60.120.200 | |
| Domain | FN3 | 1.44e-04 | 199 | 223 | 10 | PS50853 | |
| Domain | Somatomedin_B_dom | 1.89e-04 | 10 | 223 | 3 | IPR001212 | |
| Domain | SMB_1 | 1.89e-04 | 10 | 223 | 3 | PS00524 | |
| Domain | IG_FLMN | 1.89e-04 | 10 | 223 | 3 | SM00557 | |
| Domain | SMB_2 | 1.89e-04 | 10 | 223 | 3 | PS50958 | |
| Domain | Ig_E-set | 2.51e-04 | 104 | 223 | 7 | IPR014756 | |
| Domain | Filamin | 2.58e-04 | 11 | 223 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 2.58e-04 | 11 | 223 | 3 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 2.58e-04 | 11 | 223 | 3 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 2.58e-04 | 11 | 223 | 3 | IPR017868 | |
| Domain | IGv | 2.75e-04 | 75 | 223 | 6 | SM00406 | |
| Domain | Cadherin_CS | 3.35e-04 | 109 | 223 | 7 | IPR020894 | |
| Domain | Znf_C2H2_matrin | 3.41e-04 | 12 | 223 | 3 | IPR000690 | |
| Domain | CADHERIN_1 | 4.17e-04 | 113 | 223 | 7 | PS00232 | |
| Domain | Cadherin | 4.17e-04 | 113 | 223 | 7 | PF00028 | |
| Domain | Thioredoxin/glutathione_Rdtase | 4.22e-04 | 3 | 223 | 2 | IPR006338 | |
| Domain | PROLINE_PEPTIDASE | 4.22e-04 | 3 | 223 | 2 | PS00491 | |
| Domain | pKID | 4.22e-04 | 3 | 223 | 2 | PF02173 | |
| Domain | KID | 4.22e-04 | 3 | 223 | 2 | PS50953 | |
| Domain | Coactivator_CBP_pKID | 4.22e-04 | 3 | 223 | 2 | IPR003102 | |
| Domain | Peptidase_M24B_aminopep-P_CS | 4.22e-04 | 3 | 223 | 2 | IPR001131 | |
| Domain | CADHERIN_2 | 4.39e-04 | 114 | 223 | 7 | PS50268 | |
| Domain | - | 4.39e-04 | 114 | 223 | 7 | 2.60.40.60 | |
| Domain | CA | 4.63e-04 | 115 | 223 | 7 | SM00112 | |
| Domain | Ig_I-set | 4.77e-04 | 190 | 223 | 9 | IPR013098 | |
| Domain | I-set | 4.77e-04 | 190 | 223 | 9 | PF07679 | |
| Domain | ig | 4.77e-04 | 190 | 223 | 9 | PF00047 | |
| Domain | Immunoglobulin | 4.77e-04 | 190 | 223 | 9 | IPR013151 | |
| Domain | Alkaline_phosphatase_core | 4.83e-04 | 31 | 223 | 4 | IPR017850 | |
| Domain | Alkaline_Pase-like_a/b/a | 4.83e-04 | 31 | 223 | 4 | IPR017849 | |
| Domain | - | 4.83e-04 | 31 | 223 | 4 | 3.40.720.10 | |
| Domain | Cadherin-like | 4.88e-04 | 116 | 223 | 7 | IPR015919 | |
| Domain | IG | MYLK PSG11 OBSCN LRIG2 IGSF10 HMCN2 PIGR PVR SDK1 NRCAM CD7 CSF1R HMCN1 CD22 | 5.62e-04 | 421 | 223 | 14 | SM00409 |
| Domain | Ig_sub | MYLK PSG11 OBSCN LRIG2 IGSF10 HMCN2 PIGR PVR SDK1 NRCAM CD7 CSF1R HMCN1 CD22 | 5.62e-04 | 421 | 223 | 14 | IPR003599 |
| Domain | Laminin_G | 6.35e-04 | 58 | 223 | 5 | IPR001791 | |
| Domain | fn3 | 7.46e-04 | 162 | 223 | 8 | PF00041 | |
| Domain | Prot_kinase_dom | STK36 MYLK MAP3K20 OBSCN WNK1 BLK MET PIM1 BTK TRIB2 CSF1R CSNK1G2 STK38L TRIB1 EPHA4 | 8.23e-04 | 489 | 223 | 15 | IPR000719 |
| Domain | Kinase-like_dom | STK36 MYLK MAP3K20 OBSCN WNK1 BLK MET PIM1 BTK TRIB2 CSF1R CSNK1G2 PRKDC STK38L TRIB1 EPHA4 | 8.35e-04 | 542 | 223 | 16 | IPR011009 |
| Domain | G2F | 8.38e-04 | 4 | 223 | 2 | PF07474 | |
| Domain | Leuzip_CREB | 8.38e-04 | 4 | 223 | 2 | IPR001630 | |
| Domain | Creatinase/Aminopeptidase_P_N | 8.38e-04 | 4 | 223 | 2 | IPR028980 | |
| Domain | Tribbles/Ser_Thr_kinase_40 | 8.38e-04 | 4 | 223 | 2 | IPR024104 | |
| Domain | NIDOGEN_G2 | 8.38e-04 | 4 | 223 | 2 | PS50993 | |
| Domain | GFP | 8.38e-04 | 4 | 223 | 2 | IPR009017 | |
| Domain | G2_nidogen/fibulin_G2F | 8.38e-04 | 4 | 223 | 2 | IPR006605 | |
| Domain | IG_LIKE | MYLK PSG11 OBSCN LRIG2 IGSF10 HMCN2 PIGR PVR SDK1 NRCAM LEPR CD7 CSF1R HMCN1 CD22 | 8.58e-04 | 491 | 223 | 15 | PS50835 |
| Domain | PROTEIN_KINASE_DOM | STK36 MYLK MAP3K20 OBSCN WNK1 BLK MET PIM1 BTK TRIB2 CSF1R CSNK1G2 STK38L TRIB1 EPHA4 | 8.94e-04 | 493 | 223 | 15 | PS50011 |
| Domain | PROTEIN_KINASE_TYR | 1.08e-03 | 97 | 223 | 6 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.08e-03 | 97 | 223 | 6 | IPR008266 | |
| Domain | Ig-like_dom | MYLK PSG11 OBSCN LRIG2 IGSF10 HMCN2 PIGR PVR SDK1 NRCAM LEPR CD7 CSF1R HMCN1 CD22 | 1.09e-03 | 503 | 223 | 15 | IPR007110 |
| Domain | ZF_MATRIN | 1.20e-03 | 18 | 223 | 3 | PS50171 | |
| Domain | Pyr_OxRdtase_I_AS | 1.39e-03 | 5 | 223 | 2 | IPR012999 | |
| Domain | Creatin/AminoP/Spt16_NTD | 1.39e-03 | 5 | 223 | 2 | IPR029149 | |
| Domain | Pyr_redox_dim | 1.39e-03 | 5 | 223 | 2 | PF02852 | |
| Domain | PYRIDINE_REDOX_1 | 1.39e-03 | 5 | 223 | 2 | PS00076 | |
| Domain | - | 1.39e-03 | 5 | 223 | 2 | 3.40.350.10 | |
| Domain | Somatomedin_B_chordata | 1.39e-03 | 5 | 223 | 2 | IPR020436 | |
| Domain | PKD/REJ-like | 2.06e-03 | 6 | 223 | 2 | IPR002859 | |
| Domain | REJ | 2.06e-03 | 6 | 223 | 2 | PF02010 | |
| Domain | GLUTAREDOXIN_1 | 2.06e-03 | 6 | 223 | 2 | PS00195 | |
| Domain | ACTININ_2 | 2.49e-03 | 23 | 223 | 3 | PS00020 | |
| Domain | ACTININ_1 | 2.49e-03 | 23 | 223 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 2.49e-03 | 23 | 223 | 3 | IPR001589 | |
| Domain | TSPN | 2.49e-03 | 23 | 223 | 3 | SM00210 | |
| Domain | Ig_V-set | 2.75e-03 | 199 | 223 | 8 | IPR013106 | |
| Domain | - | 2.86e-03 | 7 | 223 | 2 | 3.30.390.30 | |
| Domain | CUE | 2.86e-03 | 7 | 223 | 2 | SM00546 | |
| Domain | Rab_bind | 2.86e-03 | 7 | 223 | 2 | PF16704 | |
| Domain | GCC2_Rab_bind | 2.86e-03 | 7 | 223 | 2 | IPR032023 | |
| Domain | P-loop_NTPase | ATP6V1A MYH2 MYH3 ABCA12 RHOU DDX46 EHD1 ABCD4 ASCC3 DNAH5 GNL1 RAC1 RAC2 RAC3 NWD1 DHX57 DICER1 ABCB9 DSEL DNAH11 | 2.97e-03 | 848 | 223 | 20 | IPR027417 |
| Domain | VWFA | 3.00e-03 | 82 | 223 | 5 | PS50234 | |
| Domain | VWA | 3.33e-03 | 84 | 223 | 5 | SM00327 | |
| Domain | EGF_CA | 3.47e-03 | 122 | 223 | 6 | SM00179 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 1.83e-05 | 28 | 169 | 5 | M47655 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 2.61e-05 | 30 | 169 | 5 | M47718 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 2.63e-05 | 73 | 169 | 7 | MM15126 | |
| Pathway | WP_FOCAL_ADHESION | 2.79e-05 | 199 | 169 | 11 | M39402 | |
| Pathway | WP_OVARIAN_INFERTILITY | 5.66e-05 | 35 | 169 | 5 | MM15948 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GH_TO_ITGA_B_RHOA_SIGNALING_PATHWAY | 5.72e-05 | 7 | 169 | 3 | M47538 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.43e-04 | 199 | 169 | 10 | M7253 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 1.53e-04 | 96 | 169 | 7 | MM14592 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGG_FCGR_RAC_SIGNALING_PATHWAY | 1.91e-04 | 10 | 169 | 3 | M47727 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 2.57e-04 | 74 | 169 | 6 | M160 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 2.60e-04 | 11 | 169 | 3 | M48099 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 2.63e-04 | 48 | 169 | 5 | MM15069 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 3.44e-04 | 12 | 169 | 3 | M39408 | |
| Pubmed | 6.53e-10 | 8 | 229 | 5 | 33749946 | ||
| Pubmed | 1.83e-09 | 4 | 229 | 4 | 11694340 | ||
| Pubmed | 1.83e-09 | 4 | 229 | 4 | 9321470 | ||
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 1.83e-09 | 4 | 229 | 4 | 26232607 | |
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 1.83e-09 | 4 | 229 | 4 | 11883873 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 1.83e-09 | 4 | 229 | 4 | 16963411 | |
| Pubmed | 1.83e-09 | 4 | 229 | 4 | 7670487 | ||
| Pubmed | 1.83e-09 | 4 | 229 | 4 | 19223287 | ||
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 1.83e-09 | 4 | 229 | 4 | 11688365 | |
| Pubmed | 1.83e-09 | 4 | 229 | 4 | 12752250 | ||
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 1.83e-09 | 4 | 229 | 4 | 12801575 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 1.83e-09 | 4 | 229 | 4 | 15066457 | |
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 1.83e-09 | 4 | 229 | 4 | 11095434 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 1.83e-09 | 4 | 229 | 4 | 10936047 | |
| Pubmed | PRPSAP1 ABCA12 OBSCN MFGE8 NUP210 DNAH5 SDK1 PLXNA3 FLNA FLNC FN1 CD22 PDCD11 | 2.12e-09 | 214 | 229 | 13 | 22199357 | |
| Pubmed | 2.91e-09 | 10 | 229 | 5 | 9922113 | ||
| Pubmed | ATP6V1A CLGN ILF3 ENPP1 TAB2 SLC7A11 DDOST UBA1 PVR ASCC3 FLNA FLNB FLNC NOL9 YWHAB PDIA3 GADL1 PDCD11 | 4.46e-09 | 484 | 229 | 18 | 31995728 | |
| Pubmed | RGPD4 MYH2 MYH3 ILF3 MYLK CENPF ACO2 MATR3 IFIT5 STOX1 RUNDC3A CLCN4 NDUFA12 SACS CLRN3 RGPD3 RAC1 RAC3 PLXNA3 FLNA FLNB FLNC SMIM12 PCLO DHX57 YWHAB PDIA3 ABCB9 SH3PXD2A PRKDC EPHA4 | 7.65e-09 | 1442 | 229 | 31 | 35575683 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | TMEM67 MBTPS1 CLGN ENPP1 EXT2 WDR25 ITGA7 SLC7A11 DDOST LRIG2 IGSF10 MET FAP FAT1 UBA1 PVR NUP210 PLXNA3 COL12A1 KIAA1549 CTSA YWHAB PDIA3 MADD R3HDM1 DSEL SOAT1 SORL1 | 7.84e-09 | 1201 | 229 | 28 | 35696571 |
| Pubmed | 9.11e-09 | 5 | 229 | 4 | 23579190 | ||
| Pubmed | 9.11e-09 | 5 | 229 | 4 | 22293198 | ||
| Pubmed | 9.11e-09 | 5 | 229 | 4 | 11089564 | ||
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 9.11e-09 | 5 | 229 | 4 | 10393944 | |
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 9.11e-09 | 5 | 229 | 4 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 9.11e-09 | 5 | 229 | 4 | 26411291 | |
| Pubmed | 9.11e-09 | 5 | 229 | 4 | 8896558 | ||
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 9.11e-09 | 5 | 229 | 4 | 22021443 | |
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 9.11e-09 | 5 | 229 | 4 | 10903443 | |
| Pubmed | 9.11e-09 | 5 | 229 | 4 | 9143498 | ||
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 9.11e-09 | 5 | 229 | 4 | 19783541 | |
| Pubmed | 9.11e-09 | 5 | 229 | 4 | 17761180 | ||
| Pubmed | 9.11e-09 | 5 | 229 | 4 | 23298641 | ||
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 9.11e-09 | 5 | 229 | 4 | 23223451 | |
| Pubmed | 9.11e-09 | 5 | 229 | 4 | 11804965 | ||
| Pubmed | 9.11e-09 | 5 | 229 | 4 | 8661148 | ||
| Pubmed | 9.11e-09 | 5 | 229 | 4 | 20008336 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 9.11e-09 | 5 | 229 | 4 | 8679003 | |
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 9.11e-09 | 5 | 229 | 4 | 17416365 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 9.11e-09 | 5 | 229 | 4 | 8968756 | |
| Pubmed | 9.11e-09 | 5 | 229 | 4 | 8968755 | ||
| Pubmed | 9.11e-09 | 5 | 229 | 4 | 34985827 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 9.11e-09 | 5 | 229 | 4 | 14648873 | |
| Pubmed | 9.11e-09 | 5 | 229 | 4 | 9700189 | ||
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 9.11e-09 | 5 | 229 | 4 | 9288969 | |
| Pubmed | 9.11e-09 | 5 | 229 | 4 | 23456578 | ||
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 9.11e-09 | 5 | 229 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 9.11e-09 | 5 | 229 | 4 | 8845845 | |
| Pubmed | 9.11e-09 | 5 | 229 | 4 | 11058556 | ||
| Pubmed | 9.11e-09 | 5 | 229 | 4 | 19468308 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 9.11e-09 | 5 | 229 | 4 | 12200456 | |
| Pubmed | 9.11e-09 | 5 | 229 | 4 | 11514340 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 9.11e-09 | 5 | 229 | 4 | 22223682 | |
| Pubmed | 9.11e-09 | 5 | 229 | 4 | 21270429 | ||
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 2.72e-08 | 6 | 229 | 4 | 18452650 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 2.72e-08 | 6 | 229 | 4 | 31355046 | |
| Pubmed | 2.72e-08 | 6 | 229 | 4 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 2.72e-08 | 6 | 229 | 4 | 26077710 | |
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 2.72e-08 | 6 | 229 | 4 | 14611632 | |
| Pubmed | 2.72e-08 | 6 | 229 | 4 | 17219433 | ||
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 2.72e-08 | 6 | 229 | 4 | 16001084 | |
| Pubmed | 2.72e-08 | 6 | 229 | 4 | 32962040 | ||
| Pubmed | 2.72e-08 | 6 | 229 | 4 | 11390979 | ||
| Pubmed | 2.72e-08 | 6 | 229 | 4 | 27632217 | ||
| Pubmed | 2.72e-08 | 6 | 229 | 4 | 24086306 | ||
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 2.72e-08 | 6 | 229 | 4 | 19247806 | |
| Pubmed | 2.72e-08 | 6 | 229 | 4 | 20157580 | ||
| Pubmed | 2.72e-08 | 6 | 229 | 4 | 17526644 | ||
| Pubmed | 2.72e-08 | 6 | 229 | 4 | 1638086 | ||
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 2.72e-08 | 6 | 229 | 4 | 15066460 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 2.72e-08 | 6 | 229 | 4 | 23417416 | |
| Pubmed | 2.72e-08 | 6 | 229 | 4 | 32170089 | ||
| Pubmed | 2.72e-08 | 6 | 229 | 4 | 16278232 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 2.72e-08 | 6 | 229 | 4 | 1869307 | |
| Pubmed | 6.31e-08 | 7 | 229 | 4 | 22699423 | ||
| Pubmed | 6.31e-08 | 7 | 229 | 4 | 11604102 | ||
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 6.31e-08 | 7 | 229 | 4 | 16946704 | |
| Pubmed | 6.31e-08 | 7 | 229 | 4 | 11410654 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 6.31e-08 | 7 | 229 | 4 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 6.31e-08 | 7 | 229 | 4 | 26826184 | |
| Pubmed | 6.31e-08 | 7 | 229 | 4 | 15081113 | ||
| Pubmed | 6.31e-08 | 7 | 229 | 4 | 10857750 | ||
| Pubmed | ATP6V1A ILF3 MAP1A ACO2 MATR3 NARS1 DGKB MDH1 UBA1 PNPLA6 NDUFA12 SACS EHD1 HSPA1A HSPA1B RAC1 FLNA FLNB FLNC FN1 NRCAM OXR1 PCLO KIAA1549 DHX57 YWHAB PDIA3 MADD DNAH11 | 8.61e-08 | 1431 | 229 | 29 | 37142655 | |
| Pubmed | 1.26e-07 | 8 | 229 | 4 | 29883445 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 1.26e-07 | 8 | 229 | 4 | 32339196 | |
| Pubmed | 1.26e-07 | 8 | 229 | 4 | 22621333 | ||
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 1.26e-07 | 8 | 229 | 4 | 23204224 | |
| Pubmed | 1.26e-07 | 8 | 229 | 4 | 10823932 | ||
| Pubmed | 1.26e-07 | 8 | 229 | 4 | 11869379 | ||
| Pubmed | 1.26e-07 | 8 | 229 | 4 | 10951504 | ||
| Pubmed | 1.26e-07 | 8 | 229 | 4 | 32686646 | ||
| Pubmed | ACO2 MATR3 NARS1 RSRC2 WNK1 RUNDC3A UBA1 SACS SECISBP2 HSPA1A HSPA1B TRIB2 MON1A ATXN1L TENT5B RBFOX1 LRP2 R3HDM1 | 1.41e-07 | 608 | 229 | 18 | 16713569 | |
| Pubmed | PRPSAP1 ILF3 MATR3 TAB2 RB1CC1 MDH1 UBA1 CIZ1 HSPA1A FLNA FLNB FLNC YWHAB PDIA3 TAB3 PRKDC STK38L | 1.78e-07 | 551 | 229 | 17 | 34728620 | |
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 2.25e-07 | 9 | 229 | 4 | 16310179 | |
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 2.25e-07 | 9 | 229 | 4 | 26378784 | |
| Pubmed | 2.25e-07 | 9 | 229 | 4 | 20159962 | ||
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 2.25e-07 | 9 | 229 | 4 | 19695304 | |
| Pubmed | 2.25e-07 | 9 | 229 | 4 | 28235998 | ||
| Pubmed | rac, a novel ras-related family of proteins that are botulinum toxin substrates. | 2.82e-07 | 3 | 229 | 3 | 2674130 | |
| Pubmed | 2.82e-07 | 3 | 229 | 3 | 12393796 | ||
| Pubmed | 2.82e-07 | 3 | 229 | 3 | 11153914 | ||
| Interaction | LGALS1 interactions | ENPP1 ITGA7 MET PIGR HSPA1A SDK1 RAC1 RAC2 FLNA FN1 NRCAM FAT3 KIAA1549 IFNAR1 CD7 LRP2 SORL1 | 2.01e-07 | 332 | 224 | 17 | int:LGALS1 |
| Interaction | BTNL2 interactions | TMEM67 MBTPS1 EXT2 ITGA7 LRIG2 MET MFGE8 PVR PLXNA3 ANKRD46 SORL1 | 1.33e-06 | 155 | 224 | 11 | int:BTNL2 |
| Interaction | LGALS9 interactions | ATP6V1A CLGN ILF3 ENPP1 SLC7A11 DDOST MET UBA1 PVR ASCC3 FLNA FLNB FLNC FN1 KIAA1549 NOL9 YWHAB PDIA3 GADL1 PDCD11 SORL1 | 2.77e-06 | 588 | 224 | 21 | int:LGALS9 |
| Interaction | SOCS1 interactions | PRPSAP1 BLK MET PIM1 HSPA1A FAT3 DICER1 MADD IFNAR1 CSF1R PRKDC | 4.85e-06 | 177 | 224 | 11 | int:SOCS1 |
| Interaction | TNS3 interactions | 5.65e-06 | 87 | 224 | 8 | int:TNS3 | |
| Interaction | ABL2 interactions | 2.61e-05 | 107 | 224 | 8 | int:ABL2 | |
| Interaction | OR10A4 interactions | 2.64e-05 | 6 | 224 | 3 | int:OR10A4 | |
| Interaction | GML interactions | 4.41e-05 | 58 | 224 | 6 | int:GML | |
| Interaction | MTDH interactions | PRPSAP1 ILF3 ABCA12 OBSCN MFGE8 NUP210 DNAH5 SDK1 RAC2 RAC3 PLXNA3 FLNA FLNC FN1 CD22 PDCD11 TOPORS | 5.33e-05 | 505 | 224 | 17 | int:MTDH |
| Interaction | PIK3R2 interactions | 5.58e-05 | 230 | 224 | 11 | int:PIK3R2 | |
| Interaction | FBXO2 interactions | ENPP1 CREG1 LRIG2 MET DUOX1 PVR NUP210 ENPP5 PLXNA3 COL12A1 FN1 LEPR ANKRD46 LRP2 SORL1 | 6.02e-05 | 411 | 224 | 15 | int:FBXO2 |
| Cytoband | 6q16 | 2.45e-04 | 5 | 229 | 2 | 6q16 | |
| Cytoband | 2q34 | 3.66e-04 | 28 | 229 | 3 | 2q34 | |
| Cytoband | 8q11 | 3.67e-04 | 6 | 229 | 2 | 8q11 | |
| GeneFamily | Cadherin related | 1.16e-05 | 17 | 156 | 4 | 24 | |
| GeneFamily | Rho family GTPases | 2.32e-05 | 20 | 156 | 4 | 390 | |
| GeneFamily | Fibronectin type III domain containing | 7.56e-05 | 160 | 156 | 8 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.90e-05 | 161 | 156 | 8 | 593 | |
| GeneFamily | Collagens|Collagen proteoglycans | 7.27e-04 | 5 | 156 | 2 | 575 | |
| GeneFamily | Fibulins | 2.00e-03 | 8 | 156 | 2 | 556 | |
| GeneFamily | RNA binding motif containing | 2.53e-03 | 213 | 156 | 7 | 725 | |
| Coexpression | BILD_HRAS_ONCOGENIC_SIGNATURE | MDH1 PIM1 PVR EHD1 FLNB COL12A1 FN1 CDCP1 TENT5B TRIB1 EPHA4 AHNAK2 | 2.25e-06 | 252 | 227 | 12 | M12029 |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 2.57e-06 | 12 | 227 | 4 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 2.57e-06 | 12 | 227 | 4 | MM781 | |
| Coexpression | KIM_ALL_DISORDERS_CALB1_CORR_UP | PRPSAP1 ATP6V1A MBTPS1 NARS1 DGKB RSRC2 MDH1 CREG1 DDOST RUNDC3A UBA1 TRIB2 YWHAB MADD ANKRD46 AHNAK2 SORL1 | 6.40e-06 | 547 | 227 | 17 | M2110 |
| Coexpression | OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN | 1.22e-05 | 35 | 227 | 5 | M13220 | |
| Coexpression | GSE25677_MPL_VS_R848_STIM_BCELL_DN | 3.03e-05 | 181 | 227 | 9 | M8187 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | PRPSAP1 MBTPS1 ENPP2 ITGA7 PNPLA6 NUP210 FLNA FLNC DICER1 ABCB9 SORL1 | 3.15e-05 | 276 | 227 | 11 | M3063 |
| Coexpression | GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN | 3.30e-05 | 183 | 227 | 9 | M8189 | |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 4.26e-05 | 23 | 227 | 4 | MM1293 | |
| Coexpression | LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP | 4.48e-05 | 74 | 227 | 6 | M515 | |
| Coexpression | PRC2_EED_DN.V1_UP | 4.61e-05 | 191 | 227 | 9 | M2736 | |
| Coexpression | KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MOS_DN | WNK1 FBXO38 BTK NFYC SETD3 HSPA1A ZMYND15 MGAM WASF2 ATF1 PRKDC R3HDM1 | 4.78e-05 | 342 | 227 | 12 | M41062 |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 6.46e-05 | 155 | 227 | 8 | M39246 | |
| Coexpression | GSE27786_LSK_VS_NKCELL_UP | 6.58e-05 | 200 | 227 | 9 | M4751 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | ATP6V1A MYH3 MYLK ENPP2 MAP3K20 DGKB MDH1 DDOST MET FAP MFGE8 HOXD10 CLRN3 ENPP5 FLNA COL12A1 FN1 FAT3 ADAMTS8 SLC17A1 ATP6V0A4 FUT9 LRP2 WDFY3 STK38L SORL1 | 2.24e-06 | 905 | 218 | 26 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_F-vs-M_top280_280 | CLGN ENPP1 MAP3K20 RSRC2 FREM1 FOCAD MRPS30 FBXO38 RABGAP1L PITX1 LEPR ANKRD46 SORL1 | 3.12e-06 | 260 | 218 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_250_F-vs-M |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.80e-06 | 122 | 218 | 9 | Facebase_RNAseq_e8.5_Floor Plate_1000_K2 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | MYLK RHOU FREM1 IGSF10 STOX2 HOXD10 HSPA1A HSPA1B FLNA FLNC TRIB2 FAT3 HMCN1 DSEL | 1.06e-05 | 336 | 218 | 14 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.SLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-1 | WNK1 SLC7A11 MET MFGE8 RABGAP1L PVR HSPA1A HSPA1B ZMYND15 IRF8 CDCP1 SLCO5A1 CD7 SLC2A6 | 3.68e-05 | 376 | 218 | 14 | GSM854290_500 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_1000 | ATP6V1A ENPP2 MDH1 MET CLRN3 ENPP5 SLC17A1 ATP6V0A4 FUT9 LRP2 SORL1 | 7.21e-05 | 256 | 218 | 11 | gudmap_kidney_P0_JuxtaGlom_Ren1_k4_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | ENPP2 MAP3K20 DGKB MET FAP MFGE8 CLRN3 FLNA COL12A1 FN1 SLC17A1 ATP6V0A4 FUT9 LRP2 STK38L | 7.95e-05 | 456 | 218 | 15 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_100 | 1.21e-04 | 10 | 218 | 3 | gudmap_kidney_P1_CapMes_Crym_k2_100 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STK36 ABCA12 OBSCN DGKB PKD1L2 FREM1 FAT1 DNAH5 SDK1 MGAM COL9A1 COL12A1 NRCAM FAT3 PCLO LOXHD1 HMCN1 LRP2 DNAH11 | 2.02e-19 | 184 | 229 | 19 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STK36 ABCA12 OBSCN DGKB PKD1L2 FREM1 FAT1 DNAH5 SDK1 MGAM COL9A1 COL12A1 NRCAM FAT3 PCLO LOXHD1 HMCN1 LRP2 DNAH11 | 2.02e-19 | 184 | 229 | 19 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STK36 ABCA12 OBSCN DGKB PKD1L2 FREM1 FAT1 DNAH5 SDK1 MGAM COL9A1 COL12A1 NRCAM FAT3 PCLO LOXHD1 HMCN1 LRP2 DNAH11 | 2.02e-19 | 184 | 229 | 19 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MYLK DGKB CDH23 ITGA7 COL21A1 FLNA FLNC NRCAM ADAMTS8 SLCO5A1 GADL1 DNAH11 | 5.02e-10 | 197 | 229 | 12 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 |
| ToppCell | facs-Heart-RV-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-09 | 172 | 229 | 11 | 64d2edbd8e2640b76225597883b1a524e6b1dd3b | |
| ToppCell | facs-Heart-RV-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-09 | 172 | 229 | 11 | 2dcc9d67d6ecc35940eabbc8ed528f5f884f6976 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | ITGA7 INPP4B FAP MFGE8 COL21A1 FLNA COL12A1 FN1 ADAMTS8 RBM20 SH3PXD2A | 4.82e-09 | 191 | 229 | 11 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MYLK ITGA7 INPP4B HMCN2 SACS FLNA FLNC FN1 FAT3 RBM20 STK38L | 6.66e-09 | 197 | 229 | 11 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MYLK DGKB ITGA7 INPP4B HMCN2 SACS FLNA FLNC FAT3 RBM20 GADL1 | 7.80e-09 | 200 | 229 | 11 | a66449b22b39dd6987fc2c3ed160d24564234ced |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 5.18e-08 | 188 | 229 | 10 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MYLK MAP3K20 DGKB ITGA7 INPP4B MFGE8 COL21A1 FLNA RBM20 DNAH11 | 6.32e-08 | 192 | 229 | 10 | 24e2f15f5767a97eb3b389922bcfd7b13805e1ce |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | TMEM67 STOX1 IGSF10 COL21A1 DNAH5 SDK1 CFAP91 NWD1 AHNAK2 DNAH11 | 6.64e-08 | 193 | 229 | 10 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | MYLK MAP3K20 ITGA7 INPP4B FAP MFGE8 COL21A1 FLNA COL12A1 FN1 | 6.97e-08 | 194 | 229 | 10 | ebb038f94f49f5c655578d1b018676e10c6b7e3c |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 7.31e-08 | 195 | 229 | 10 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.67e-08 | 196 | 229 | 10 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | (2)_Fibroblasts-(23)_Fibro-4|World / Cell class and subclass of bone marrow stroma cells in homeostatis | ENPP1 PTPN22 RABGAP1L PITX1 FN1 TMPRSS6 KIAA1549 ATP6V0A4 STK38L AHNAK2 | 8.04e-08 | 197 | 229 | 10 | a183919023a4aca90a06be0e5e89c817b38c5574 |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MYLK DGKB ITGA7 COL21A1 FLNA FLNC NRCAM SLCO5A1 GADL1 DNAH11 | 8.43e-08 | 198 | 229 | 10 | c12e7511628db819a52959bb68580e27c00c2e41 |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.43e-08 | 198 | 229 | 10 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MYLK DGKB ITGA7 COL21A1 FLNA FLNC NRCAM SLCO5A1 GADL1 DNAH11 | 8.43e-08 | 198 | 229 | 10 | 22e766df1276c5b14aa0d83f434f47140ebb98ea |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-07 | 160 | 229 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-07 | 160 | 229 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-07 | 168 | 229 | 9 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | facs-Heart-RV-18m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-07 | 172 | 229 | 9 | d061ea21bee179df5a525842e9a48621a8e1461b | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 2.94e-07 | 173 | 229 | 9 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.94e-07 | 173 | 229 | 9 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-07 | 178 | 229 | 9 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.74e-07 | 178 | 229 | 9 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 4.11e-07 | 180 | 229 | 9 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.51e-07 | 182 | 229 | 9 | 728a2152c166551ac229370c0900fe2bc426ea9b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.95e-07 | 184 | 229 | 9 | 54e5b63f55b8d6eccad53d389ea9c78f991e1414 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 4.95e-07 | 184 | 229 | 9 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.95e-07 | 184 | 229 | 9 | 7b5678718719020b52e7c2a7bd9797987defd7ff | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.67e-07 | 187 | 229 | 9 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-07 | 187 | 229 | 9 | accb8a78b885703a27d4b560f0053f03d82ff3af | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.92e-07 | 188 | 229 | 9 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.19e-07 | 189 | 229 | 9 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 6.19e-07 | 189 | 229 | 9 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.47e-07 | 190 | 229 | 9 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-07 | 191 | 229 | 9 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-07 | 191 | 229 | 9 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.76e-07 | 191 | 229 | 9 | de2cd94ee88a7754f86d39469e38374d668210c7 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-07 | 191 | 229 | 9 | ff7874cc005760a8f3b2e8072fbe418b6bfacaa8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-07 | 191 | 229 | 9 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.07e-07 | 192 | 229 | 9 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-07 | 193 | 229 | 9 | b9e11cd0896c0868aab7faec4ab7ab4d4e4d1b47 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.38e-07 | 193 | 229 | 9 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 7.38e-07 | 193 | 229 | 9 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.70e-07 | 194 | 229 | 9 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.70e-07 | 194 | 229 | 9 | d2bafd31bb8333f66b6c714944bceb2f1aa11740 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 8.04e-07 | 195 | 229 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.04e-07 | 195 | 229 | 9 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-07 | 196 | 229 | 9 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.39e-07 | 196 | 229 | 9 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-07 | 196 | 229 | 9 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-07 | 196 | 229 | 9 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.13e-07 | 198 | 229 | 9 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.13e-07 | 198 | 229 | 9 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.93e-07 | 200 | 229 | 9 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | medial-2-mesenchymal-Airway_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | MYLK MAP3K20 ITGA7 INPP4B MFGE8 COL21A1 FLNC COL12A1 ADAMTS8 | 9.93e-07 | 200 | 229 | 9 | 16b00eacbea4d75cf814803d3fc0b82c2b8c0a9c |
| ToppCell | medial-mesenchymal-Airway_Smooth_Muscle|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | MYLK MAP3K20 ITGA7 INPP4B MFGE8 COL21A1 FLNC COL12A1 ADAMTS8 | 9.93e-07 | 200 | 229 | 9 | c1d9748aaae489d26e24602a5dcbe7f5fa9a5548 |
| ToppCell | medial-mesenchymal-Airway_Smooth_Muscle-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | MYLK MAP3K20 ITGA7 INPP4B MFGE8 COL21A1 FLNC COL12A1 ADAMTS8 | 9.93e-07 | 200 | 229 | 9 | 6a5047018b12be3bc4b55a64d42e52e96c624003 |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-leukocyte-proliferating_myeloid_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-06 | 153 | 229 | 8 | 596bb7cfd1c713708ce73df30d890a0233eae7f7 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-leukocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-06 | 153 | 229 | 8 | 8cc2667213bfac37545bb63181e88ef1f1834413 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Cbln4_Fezf2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.83e-06 | 160 | 229 | 8 | d8241404d775f9a709abdf17988f36293fcf4c58 | |
| ToppCell | ASK428-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.63e-06 | 168 | 229 | 8 | c399fcb4d1d0be48026c2ecabc34a5935e7adf73 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.63e-06 | 168 | 229 | 8 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.27e-06 | 173 | 229 | 8 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-06 | 173 | 229 | 8 | 901b8e6909c1f3849906fad9cee17b8f0bab050d | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-06 | 173 | 229 | 8 | fc2602b2ce051cd4c33957d7e3d041ff8a529883 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-06 | 173 | 229 | 8 | 2cba41c3d9d3076f703115d19729073a3ac3feb6 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-06 | 173 | 229 | 8 | 11d69a4ab4a87b8820cd3bd204de8c4124450a90 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.42e-06 | 174 | 229 | 8 | 4120656e6d6cf5435a248326b5fdbdc7b22137af | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.42e-06 | 174 | 229 | 8 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-06 | 175 | 229 | 8 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-06 | 175 | 229 | 8 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.72e-06 | 176 | 229 | 8 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.72e-06 | 176 | 229 | 8 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.72e-06 | 176 | 229 | 8 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | PBMC-Mild-cDC_11|Mild / Compartment, Disease Groups and Clusters | 3.88e-06 | 177 | 229 | 8 | 974305e4c0eff90134c4e58cf11b955d1eee0501 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.04e-06 | 178 | 229 | 8 | f7f88879a05b2b5fa92cf5317b76f7a3064d1358 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-06 | 180 | 229 | 8 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | facs-Heart-LV-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.57e-06 | 181 | 229 | 8 | 57f82f54e20e19aa17a2ea22af22e3bc8965d622 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.57e-06 | 181 | 229 | 8 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | facs-Heart-LV-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.57e-06 | 181 | 229 | 8 | 8855812c85ef45c1be6bd511619b2dfe5e441264 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.76e-06 | 182 | 229 | 8 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | facs-Heart-LV-18m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-06 | 182 | 229 | 8 | d0d18dd5d8b2d21e42c3c4259f824c91f24a54bc | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 4.96e-06 | 183 | 229 | 8 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.96e-06 | 183 | 229 | 8 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.96e-06 | 183 | 229 | 8 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 5.16e-06 | 184 | 229 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.16e-06 | 184 | 229 | 8 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | severe_influenza-RBC|World / disease group, cell group and cell class (v2) | 5.81e-06 | 187 | 229 | 8 | f846750575f318503d21ade30f5bfd2e1d4c84af | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-06 | 187 | 229 | 8 | a12f383b02b07af32cc53a154685df8dba8fbd3f | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.81e-06 | 187 | 229 | 8 | 218c9b4f28499389c43005d9626af2ac01066027 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-06 | 187 | 229 | 8 | c40c152fa14e6afc9188549534b64ccbaded56b3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.81e-06 | 187 | 229 | 8 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.81e-06 | 187 | 229 | 8 | 8ee3bf885897efd634c3a0567637142a9f55e693 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.81e-06 | 187 | 229 | 8 | c7ac4b328efc2ebb72f71154661914193ff402ca | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 5.81e-06 | 187 | 229 | 8 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.81e-06 | 187 | 229 | 8 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| Drug | boron trichloride | 1.35e-07 | 6 | 224 | 4 | CID000025135 | |
| Drug | desmethylazelastine | 3.52e-07 | 16 | 224 | 5 | CID000162558 | |
| Drug | AC1L1CB3 | 6.80e-07 | 18 | 224 | 5 | CID000001818 | |
| Drug | ridogrel | 7.46e-07 | 52 | 224 | 7 | CID005362391 | |
| Drug | YM 026 | 9.16e-07 | 19 | 224 | 5 | CID000004443 | |
| Drug | RI-64 | 9.40e-07 | 3 | 224 | 3 | CID000065758 | |
| Drug | 4mupt | 9.40e-07 | 3 | 224 | 3 | CID000196156 | |
| Drug | phenylphosphonic dichloride | 9.40e-07 | 3 | 224 | 3 | CID000069990 | |
| Drug | quinovic acid | 9.40e-07 | 3 | 224 | 3 | CID000120678 | |
| Drug | cadeguomycin | 1.11e-06 | 9 | 224 | 4 | CID000133738 | |
| Drug | Raloxifene Hydrochloride | CYP1A1 ENPP2 MATR3 MAP3K20 NARS1 SLC7A11 INPP4B TXNRD1 FAP CLCN4 PIGR PIM1 HSPA1A HSPA1B FLNB FLNC TRIB2 FN1 DICER1 HMCN1 ABCB9 FUT9 PRKDC TRIB1 EPHA4 | 1.31e-06 | 857 | 224 | 25 | ctd:D020849 |
| Drug | benzoylsalireposide | 3.73e-06 | 4 | 224 | 3 | CID000639684 | |
| Drug | hebucol | 3.73e-06 | 4 | 224 | 3 | CID000072065 | |
| Drug | Cinchonine [118-10-5]; Up 200; 13.6uM; HL60; HT_HG-U133A | CLGN CENPF WNK1 PCNX2 MET PVR CIZ1 NR3C2 PCLO XPNPEP2 RBFOX1 | 4.11e-06 | 196 | 224 | 11 | 2133_UP |
| Drug | Retrorsine [480-54-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | CLGN PTPN22 RB1CC1 SLC7A11 SAG CLCN4 PVR SERHL2 THOC5 CSF1R RBFOX1 | 4.75e-06 | 199 | 224 | 11 | 4946_UP |
| Drug | Asbestos, Crocidolite | CYP1A1 MYH3 ILF3 MYLK ACO2 MAP3K20 OR1A2 OR2H1 RSRC2 SLC7A11 INPP4B TXNRD1 MET EHD1 NR3C2 HSPA1A HSPA1B OR2H2 TRIB2 COL12A1 FN1 IRF8 CDCP1 CREB1 SLCO5A1 RNF167 OR1I1 TRIB1 IL5 EPHA4 | 5.06e-06 | 1241 | 224 | 30 | ctd:D017638 |
| Drug | PdNP | 6.08e-06 | 13 | 224 | 4 | CID000151930 | |
| Drug | 3,5-heptanedione | 9.26e-06 | 5 | 224 | 3 | CID000081923 | |
| Drug | 8-acetyl-2-(dipropylamino)tetralin | 9.26e-06 | 5 | 224 | 3 | CID000132276 | |
| Drug | d-gluconhydroximo-1,5-lactam | 1.22e-05 | 31 | 224 | 5 | CID000003479 | |
| Drug | hydroxymethyltrioxsalen | 1.51e-05 | 16 | 224 | 4 | CID000104953 | |
| Drug | saterinone | 1.84e-05 | 6 | 224 | 3 | CID000065874 | |
| Drug | B258 | 1.84e-05 | 6 | 224 | 3 | CID000593690 | |
| Drug | diadenosine diphosphate | 1.84e-05 | 6 | 224 | 3 | CID000188326 | |
| Drug | 4-methylumbelliferyl phenylphosphonate | 1.84e-05 | 6 | 224 | 3 | CID000134928 | |
| Drug | NSC343256 | 1.84e-05 | 6 | 224 | 3 | CID000335091 | |
| Drug | AC1L6XCD | 1.84e-05 | 6 | 224 | 3 | CID000325952 | |
| Drug | Oleandomycin phosphate [7060-74-4]; Up 200; 5uM; MCF7; HT_HG-U133A | MYH2 SLC7A11 MFGE8 CLCN4 PITX1 ABCD4 RAC2 SERHL2 AMELX SH3PXD2A | 2.47e-05 | 195 | 224 | 10 | 5676_UP |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; HL60; HT_HG-U133A | ENPP1 ENPP2 WDR25 SLC7A11 BLK RUNDC3A RNF167 ABCB9 RBFOX1 LRP2 | 2.58e-05 | 196 | 224 | 10 | 2174_UP |
| Drug | Vistar | 2.59e-05 | 36 | 224 | 5 | CID000040896 | |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 2.70e-05 | 197 | 224 | 10 | 4992_UP | |
| Drug | Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.82e-05 | 198 | 224 | 10 | 5416_UP | |
| Drug | Chlormezanone [80-77-3]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 2.82e-05 | 198 | 224 | 10 | 3235_UP | |
| Drug | Polyethyleneimine | 3.04e-05 | 90 | 224 | 7 | ctd:D011094 | |
| Drug | Gabazine [105538-73-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 3.07e-05 | 200 | 224 | 10 | 4820_UP | |
| Drug | dazmegrel | 3.15e-05 | 19 | 224 | 4 | CID000053555 | |
| Drug | 1-dodecanoyllysolecithin | 3.19e-05 | 7 | 224 | 3 | CID000460605 | |
| Drug | AC1L9N73 | 3.19e-05 | 7 | 224 | 3 | CID000449501 | |
| Drug | Phenol | 4.75e-05 | 131 | 224 | 8 | ctd:D019800 | |
| Drug | 11-keto-beta-boswellic acid | 5.07e-05 | 8 | 224 | 3 | CID006918114 | |
| Drug | 2,5-hexanedione | 5.62e-05 | 99 | 224 | 7 | ctd:C011269 | |
| Drug | AZFd | 6.97e-05 | 23 | 224 | 4 | CID000196489 | |
| Drug | dansylaziridine | 6.97e-05 | 23 | 224 | 4 | CID000104008 | |
| Drug | propham | 7.00e-05 | 44 | 224 | 5 | CID000024685 | |
| Drug | Organoselenium Compounds | 7.13e-05 | 71 | 224 | 6 | ctd:D016566 | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 7.34e-05 | 179 | 224 | 9 | 5590_UP | |
| Drug | coprogen | 7.56e-05 | 9 | 224 | 3 | CID006323272 | |
| Drug | ddUMP | 7.56e-05 | 9 | 224 | 3 | CID003081662 | |
| Drug | lividomycin A sulfate | 8.30e-05 | 24 | 224 | 4 | CID000003940 | |
| Drug | cyproconazole | 8.70e-05 | 46 | 224 | 5 | CID000086132 | |
| Drug | pinicolic acid | 9.64e-05 | 2 | 224 | 2 | CID005320604 | |
| Drug | GYKI 52466 | 9.64e-05 | 2 | 224 | 2 | ctd:C061950 | |
| Drug | isodApdC | 9.64e-05 | 2 | 224 | 2 | CID000477021 | |
| Drug | 5-iodoindoxyl-3-phenylphosphonate | 9.64e-05 | 2 | 224 | 2 | CID000126064 | |
| Drug | tetracenomycin C | 9.81e-05 | 25 | 224 | 4 | CID000073632 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 9.85e-05 | 186 | 224 | 9 | 7499_UP | |
| Drug | captax | 1.07e-04 | 48 | 224 | 5 | ctd:C005563 | |
| Drug | 2-(p-n-butylanilino)-2'-deoxyadenosine | 1.07e-04 | 10 | 224 | 3 | CID003062886 | |
| Drug | NSC285223 | 1.07e-04 | 10 | 224 | 3 | CID000323607 | |
| Drug | strontium ranelate | 1.12e-04 | 77 | 224 | 6 | CID006918182 | |
| Drug | AC1N9ZZC | 1.17e-04 | 149 | 224 | 8 | CID004369374 | |
| Drug | elesclomol | 1.18e-04 | 49 | 224 | 5 | ctd:C512195 | |
| Drug | MAR70 | 1.21e-04 | 78 | 224 | 6 | CID000004013 | |
| Drug | Omeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.36e-04 | 194 | 224 | 9 | 2828_UP | |
| Drug | Conessine [546-06-5]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.36e-04 | 194 | 224 | 9 | 2792_DN | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 1uM; PC3; HT_HG-U133A | 1.41e-04 | 195 | 224 | 9 | 4333_DN | |
| Drug | 4 Ig | 1.46e-04 | 11 | 224 | 3 | CID006914628 | |
| Drug | Eburnamonine (-) [4880-88-0]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.47e-04 | 196 | 224 | 9 | 2781_UP | |
| Drug | Merbromin [129-16-8]; Up 200; 5uM; MCF7; HT_HG-U133A | 1.47e-04 | 196 | 224 | 9 | 4722_UP | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; HL60; HT_HG-U133A | 1.47e-04 | 196 | 224 | 9 | 2551_DN | |
| Drug | chrysene | CYP1A1 MYLK TAB2 ITGA7 MIDEAS HMCN2 PIGR PIM1 EHD1 HSPA1A ZMYND15 TRIB2 NRCAM XPNPEP2 DICER1 LEPR HMCN1 SH3PXD2A SLC2A6 CSNK1G2 ATP6V0A4 | 1.51e-04 | 871 | 224 | 21 | ctd:C031180 |
| Drug | Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 4803_UP | |
| Drug | Gibberellic acid [77-06-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 4818_UP | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 6043_UP | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; HL60; HG-U133A | 1.52e-04 | 197 | 224 | 9 | 1977_UP | |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 4152_UP | |
| Drug | Pyrilamine maleate [59-33-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 3184_UP | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.54e-04 | 155 | 224 | 8 | 6817_DN | |
| Drug | AC1Q5PO8 | 1.55e-04 | 28 | 224 | 4 | CID000000642 | |
| Drug | Bromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 6037_UP | |
| Drug | Delcorine; Up 200; 8.4uM; HL60; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 2178_UP | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 3237_UP | |
| Drug | Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 2242_UP | |
| Drug | estradiol, USP; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 4432_UP | |
| Drug | Fluocinonide [356-12-7]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 224 | 9 | 3839_UP | |
| Drug | Harmane hydrochloride [21655-84-5]; Down 200; 18.2uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 224 | 9 | 2806_DN | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 224 | 9 | 6069_UP | |
| Drug | ICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A | CYP1A1 ABCA12 RABGAP1L PLXNA3 TRIB2 LEPR CSF1R STK38L AHNAK2 | 1.64e-04 | 199 | 224 | 9 | 6872_UP |
| Drug | Clidinium bromide [3485-62-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 224 | 9 | 3476_UP | |
| Drug | Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.71e-04 | 200 | 224 | 9 | 7261_DN | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A | 1.71e-04 | 200 | 224 | 9 | 6450_UP | |
| Drug | CD-III | 1.72e-04 | 53 | 224 | 5 | CID000066693 | |
| Drug | GSK237701A | 1.79e-04 | 29 | 224 | 4 | CID010095658 | |
| Drug | AC1Q6A7C | 1.94e-04 | 12 | 224 | 3 | CID000092807 | |
| Drug | phenylphosphonic acid | 1.94e-04 | 12 | 224 | 3 | CID000015295 | |
| Drug | BuAdATP | 1.94e-04 | 12 | 224 | 3 | CID000127308 | |
| Drug | methyl-rhamnopyranoside | 1.94e-04 | 12 | 224 | 3 | CID000084695 | |
| Disease | Partial chromosome Y deletion | 2.13e-07 | 8 | 222 | 4 | C1507149 | |
| Disease | Male sterility due to Y-chromosome deletions | 2.13e-07 | 8 | 222 | 4 | C2931163 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 4.20e-07 | 3 | 222 | 3 | DOID:0080096 (implicated_via_orthology) | |
| Disease | autosomal dominant intellectual developmental disorder 48 (implicated_via_orthology) | 4.20e-07 | 3 | 222 | 3 | DOID:0080235 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 4.20e-07 | 3 | 222 | 3 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | CYP1A1 CENPF ACO2 OBSCN RB1CC1 WNK1 INPP4B MFGE8 PIM1 BTK NFYC ACCS HSPA1B RAC2 FLNA FLNB FN1 NRCAM TMPRSS6 IRF8 LEPR THOC5 CSF1R PADI3 SORL1 | 6.28e-07 | 1074 | 222 | 25 | C0006142 |
| Disease | clubfoot (is_implicated_in) | 4.16e-06 | 5 | 222 | 3 | DOID:11836 (is_implicated_in) | |
| Disease | myopathy (implicated_via_orthology) | 3.03e-05 | 48 | 222 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME | 5.64e-05 | 2 | 222 | 2 | C1848934 | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 1.05e-04 | 62 | 222 | 5 | DOID:9074 (is_implicated_in) | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 1.70e-04 | 37 | 222 | 4 | DOID:0050545 (implicated_via_orthology) | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 2.19e-04 | 16 | 222 | 3 | C1839071 | |
| Disease | Spondyloepiphyseal Dysplasia | 2.19e-04 | 16 | 222 | 3 | C0038015 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 2.19e-04 | 16 | 222 | 3 | cv:C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 2.19e-04 | 16 | 222 | 3 | 415000 | |
| Disease | Schwartz-Jampel Syndrome | 2.19e-04 | 16 | 222 | 3 | C0036391 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 2.19e-04 | 16 | 222 | 3 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 2.19e-04 | 16 | 222 | 3 | C4551479 | |
| Disease | Melnick-Needles Syndrome | 2.19e-04 | 16 | 222 | 3 | C0025237 | |
| Disease | Breast Carcinoma | CYP1A1 CENPF RB1CC1 INPP4B MFGE8 PIM1 BTK HSPA1B FLNA FN1 NRCAM LEPR CSF1R | 2.40e-04 | 538 | 222 | 13 | C0678222 |
| Disease | Neoplasm Metastasis | 2.52e-04 | 217 | 222 | 8 | C0027627 | |
| Disease | kidney disease (implicated_via_orthology) | 2.54e-04 | 41 | 222 | 4 | DOID:557 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of prostate | CYP1A1 MBTPS1 CENPF CREG1 MET PVR CIZ1 ENPP5 HSPA1A PCDH11Y ADAMTS8 PDIA3 LRP2 PRKDC | 2.59e-04 | 616 | 222 | 14 | C0376358 |
| Disease | Prostatic Neoplasms | CYP1A1 MBTPS1 CENPF CREG1 MET PVR CIZ1 ENPP5 HSPA1A PCDH11Y ADAMTS8 PDIA3 LRP2 PRKDC | 2.59e-04 | 616 | 222 | 14 | C0033578 |
| Disease | Van Buchem disease | 2.64e-04 | 17 | 222 | 3 | C0432272 | |
| Disease | Colorectal Carcinoma | ABCA12 OBSCN WNK1 TXNRD1 FAT1 SACS ABCD4 NR3C2 FLNC FN1 NRCAM LRP2 DSEL CDH7 SORL1 | 3.03e-04 | 702 | 222 | 15 | C0009402 |
| Disease | Clear Cell Sarcoma of Soft Tissue | 3.35e-04 | 4 | 222 | 2 | C0206651 | |
| Disease | Kartagener syndrome (is_implicated_in) | 3.35e-04 | 4 | 222 | 2 | DOID:0050144 (is_implicated_in) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 3.50e-04 | 80 | 222 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | osteochondrodysplasia (is_implicated_in) | 3.72e-04 | 19 | 222 | 3 | DOID:2256 (is_implicated_in) | |
| Disease | Osteochondrodysplasias | 3.72e-04 | 19 | 222 | 3 | C0029422 | |
| Disease | Dyschondroplasias | 3.72e-04 | 19 | 222 | 3 | C0013366 | |
| Disease | Multiple Epiphyseal Dysplasia | 4.36e-04 | 20 | 222 | 3 | C0026760 | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 5.55e-04 | 5 | 222 | 2 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | Granulosa Cell Cancer | 5.55e-04 | 5 | 222 | 2 | C1567257 | |
| Disease | cardiovascular disease biomarker measurement, ankle brachial index | 5.55e-04 | 5 | 222 | 2 | EFO_0003912, EFO_0005278 | |
| Disease | Meniere's disease (is_implicated_in) | 8.29e-04 | 6 | 222 | 2 | DOID:9849 (is_implicated_in) | |
| Disease | optic cup area measurement | 8.43e-04 | 56 | 222 | 4 | EFO_0006940 | |
| Disease | Grade I Astrocytoma | 8.55e-04 | 25 | 222 | 3 | C1704230 | |
| Disease | Pilocytic Astrocytoma | 8.55e-04 | 25 | 222 | 3 | C0334583 | |
| Disease | Childhood Cerebral Astrocytoma | 8.55e-04 | 25 | 222 | 3 | C0338070 | |
| Disease | Cerebral Astrocytoma | 8.55e-04 | 25 | 222 | 3 | C0750935 | |
| Disease | Intracranial Astrocytoma | 8.55e-04 | 25 | 222 | 3 | C0750936 | |
| Disease | Astrocytoma | 8.55e-04 | 25 | 222 | 3 | C0004114 | |
| Disease | Subependymal Giant Cell Astrocytoma | 8.55e-04 | 25 | 222 | 3 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 8.55e-04 | 25 | 222 | 3 | C0547065 | |
| Disease | Juvenile Pilocytic Astrocytoma | 8.55e-04 | 25 | 222 | 3 | C0280783 | |
| Disease | Diffuse Astrocytoma | 8.55e-04 | 25 | 222 | 3 | C0280785 | |
| Disease | Gemistocytic astrocytoma | 9.61e-04 | 26 | 222 | 3 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 9.61e-04 | 26 | 222 | 3 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 9.61e-04 | 26 | 222 | 3 | C0334582 | |
| Disease | diet measurement | CYP1A1 ACO2 MIER3 INPP4B MRPS30 PHF2 FBXO3 NR3C2 DNAH5 SDK1 MGAM MMS22L LEPR RBFOX1 PRKDC TRIB1 EPHA4 SORL1 | 1.04e-03 | 1049 | 222 | 18 | EFO_0008111 |
| Disease | Anaplastic astrocytoma | 1.08e-03 | 27 | 222 | 3 | C0334579 | |
| Disease | retinal detachment | 1.15e-03 | 7 | 222 | 2 | EFO_0005773 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 1.20e-03 | 28 | 222 | 3 | DOID:4194 (implicated_via_orthology) | |
| Disease | diabetes mellitus (is_implicated_in) | 1.33e-03 | 29 | 222 | 3 | DOID:9351 (is_implicated_in) | |
| Disease | fish consumption measurement | 1.39e-03 | 64 | 222 | 4 | EFO_0010139 | |
| Disease | Ciliopathies | 1.49e-03 | 110 | 222 | 5 | C4277690 | |
| Disease | neuroticism measurement | MYH2 ACO2 RSRC2 BLK PHF2 RABGAP1L ASCC3 SDK1 MMS22L OXR1 PCLO C2orf74 MADD RBFOX1 CDH7 EPHA4 | 1.52e-03 | 909 | 222 | 16 | EFO_0007660 |
| Disease | pseudohypoaldosteronism (is_implicated_in) | 1.53e-03 | 8 | 222 | 2 | DOID:4479 (is_implicated_in) | |
| Disease | Diabetes Mellitus | 1.77e-03 | 32 | 222 | 3 | C0011849 | |
| Disease | complement factor H-related protein 3 measurement | 1.81e-03 | 169 | 222 | 6 | EFO_0600056 | |
| Disease | choroidal melanoma | 1.96e-03 | 9 | 222 | 2 | EFO_0009093 | |
| Disease | Major depression, single episode | 1.96e-03 | 9 | 222 | 2 | C0024517 | |
| Disease | chronic lymphocytic leukemia (is_marker_for) | 1.96e-03 | 9 | 222 | 2 | DOID:1040 (is_marker_for) | |
| Disease | ferritin measurement | 2.10e-03 | 119 | 222 | 5 | EFO_0004459 | |
| Disease | Mammary Carcinoma, Human | CYP1A1 CENPF RB1CC1 MFGE8 PIM1 HSPA1B FLNA FN1 NRCAM LEPR CSF1R | 2.23e-03 | 525 | 222 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | CYP1A1 CENPF RB1CC1 MFGE8 PIM1 HSPA1B FLNA FN1 NRCAM LEPR CSF1R | 2.23e-03 | 525 | 222 | 11 | C1257931 |
| Disease | Mammary Neoplasms | CYP1A1 CENPF RB1CC1 MFGE8 PIM1 HSPA1B FLNA FN1 NRCAM LEPR CSF1R | 2.29e-03 | 527 | 222 | 11 | C1458155 |
| Disease | Liver Cirrhosis, Experimental | ENPP2 MDH1 FAT1 RABGAP1L RAC2 FLNA COL12A1 IRF8 XPNPEP2 CD7 CSF1R SLC17A1 CTSE SOAT1 | 2.32e-03 | 774 | 222 | 14 | C0023893 |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.44e-03 | 10 | 222 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.44e-03 | 10 | 222 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.44e-03 | 10 | 222 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.44e-03 | 10 | 222 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | Hyperpotassemia and Hypertension, Familial | 2.44e-03 | 10 | 222 | 2 | C2713447 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Recessive | 2.44e-03 | 10 | 222 | 2 | C1449843 | |
| Disease | Pseudohypoaldosteronism, Type II | 2.44e-03 | 10 | 222 | 2 | C1449844 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Dominant | 2.44e-03 | 10 | 222 | 2 | C1449842 | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.44e-03 | 10 | 222 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.44e-03 | 10 | 222 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | Pseudohypoaldosteronism, Type I | 2.44e-03 | 10 | 222 | 2 | C0268436 | |
| Disease | decadienedioic acid (C10:2-DC) measurement | 2.44e-03 | 10 | 222 | 2 | EFO_0800598 | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.44e-03 | 10 | 222 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | Pseudohypoaldosteronism | 2.44e-03 | 10 | 222 | 2 | C0033805 | |
| Disease | rheumatoid arthritis, systemic lupus erythematosus | 2.44e-03 | 10 | 222 | 2 | EFO_0000685, MONDO_0007915 | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.44e-03 | 10 | 222 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Primary ciliary dyskinesia | 2.50e-03 | 36 | 222 | 3 | cv:C0008780 | |
| Disease | Behcet's disease (is_implicated_in) | 2.50e-03 | 36 | 222 | 3 | DOID:13241 (is_implicated_in) | |
| Disease | colorectal carcinoma (is_marker_for) | 2.70e-03 | 37 | 222 | 3 | DOID:0080199 (is_marker_for) | |
| Disease | Disproportionate short stature | 2.75e-03 | 77 | 222 | 4 | C0878659 | |
| Disease | alcohol consumption measurement | CYP1A1 SMUG1 ACO2 INPP4B STOX2 RABGAP1L NR3C2 SETD3 DNAH5 SVOP SDK1 MGAM MMS22L COL12A1 PCLO RBFOX1 TRIB1 EPHA4 SORL1 | 2.80e-03 | 1242 | 222 | 19 | EFO_0007878 |
| Disease | systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus | 2.92e-03 | 38 | 222 | 3 | EFO_0000685, EFO_0000717, EFO_0000783, MONDO_0007915 | |
| Disease | Sensory hearing loss | 2.96e-03 | 11 | 222 | 2 | C1691779 | |
| Disease | psoriatic arthritis (is_implicated_in) | 2.96e-03 | 11 | 222 | 2 | DOID:9008 (is_implicated_in) | |
| Disease | Glioblastoma | 3.02e-03 | 79 | 222 | 4 | C0017636 | |
| Disease | aortic measurement | 3.03e-03 | 251 | 222 | 7 | EFO_0020865 | |
| Disease | obsolete_red blood cell distribution width | PRPSAP1 CYP1A1 SMUG1 CDH23 WNK1 MIDEAS INPP4B PIM1 RABGAP1L NUP210 RAC1 RBM38 TMPRSS6 MON1A NOL9 LOXHD1 CD22 CSNK1G2 R3HDM1 TRIB1 | 3.06e-03 | 1347 | 222 | 20 | EFO_0005192 |
| Disease | dilated cardiomyopathy (is_marker_for) | 3.14e-03 | 39 | 222 | 3 | DOID:12930 (is_marker_for) | |
| Disease | macula measurement | 3.17e-03 | 189 | 222 | 6 | EFO_0008375 | |
| Disease | Inherited neuropathies | 3.38e-03 | 40 | 222 | 3 | C0598589 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VTQEFGPVPDTARYY | 636 | Q99798 | |
| PGYINFSYEVLTPLK | 26 | Q99217 | |
| YLIPNATQPESKVFY | 106 | P31946 | |
| PQDIIYYEDGVVPTT | 66 | P09564 | |
| PPYLANFYIFLVETG | 361 | Q6UX73 | |
| EAFLIPTPYYGAITQ | 186 | Q96QU6 | |
| PFQVVYDEGPLYVFS | 101 | Q06187 | |
| VEYYIPGSTTNPEVF | 281 | Q9H5V8 | |
| LTPTNYGYNDIVTIP | 696 | Q9UP79 | |
| SNSYPEIQISPSLYG | 1771 | Q86UK0 | |
| FYEYLGNSPRLVITP | 1856 | Q96DT5 | |
| DLYFSRVQVYPPVGA | 86 | P10523 | |
| PIGGVLFSLEEVSYY | 271 | P51793 | |
| VTAITAIIAYPNPYT | 376 | P51793 | |
| PQGIYVISAPSIYAR | 571 | Q9NYJ7 | |
| YVVIAIPIFSGVYGD | 286 | O14678 | |
| YYVSGVLPFVENQPE | 211 | Q86W74 | |
| GTFYSTLYLPINSPL | 661 | Q9UPY3 | |
| EYPTYPDSAFQVTTG | 191 | Q13117 | |
| RSPFQVTAGYQLPVY | 221 | Q13117 | |
| AYPSSPFQVTAGYQL | 266 | Q13117 | |
| AYPSSPFQVTTGYQL | 386 | Q13117 | |
| SSPFQVTTGYQLPVY | 461 | Q13117 | |
| EYPTYPDSAFQVTTG | 191 | Q9NR90 | |
| RSPFQVTAGYQLPVY | 221 | Q9NR90 | |
| AYPSSPFQVTAGYQL | 266 | Q9NR90 | |
| GTLVYSIQPPNKFYS | 811 | Q9H251 | |
| VTYTLLDLVPPGYVQ | 2331 | Q9H251 | |
| VVYAVSKAEPYTFPP | 161 | Q7Z4T9 | |
| IDGPRYTFYTQLPET | 1336 | Q149M9 | |
| QGVVIPYTSVPTYQV | 721 | Q15032 | |
| EDYASNLGTSYVPIP | 476 | Q5T481 | |
| SFVGYSYPAAVPQAL | 201 | Q9H0Z9 | |
| ISYTTNAFPGEYIPT | 21 | P15153 | |
| ISYTTNAFPGEYIPT | 21 | P60763 | |
| ISYTTNAFPGEYIPT | 21 | P63000 | |
| PGHFNPYRYVVVSVT | 181 | P04798 | |
| SALGVYSYIPLVENP | 521 | Q9Y2R2 | |
| SFYLGYPVLQIAEPF | 1141 | Q9HCM3 | |
| NVTGTPEQYVPYSTT | 116 | Q9UI09 | |
| LPSFLQKTLPEYTGY | 296 | Q9NRD9 | |
| SFVPSPYVATAPELY | 1396 | Q8TDY2 | |
| PNSTIYVVEPGYLGF | 336 | Q8TEM1 | |
| NPPVFEYREYGATVS | 3226 | Q14517 | |
| NFYVVIPPALNSVIY | 276 | Q8NGJ3 | |
| TSYPGSSYIFVQESP | 236 | Q5SY16 | |
| YVFRPGQPDASIYVV | 221 | Q8IY17 | |
| PITGIQYSVGALYTT | 391 | Q5XUX1 | |
| YVAVTPALNPFIYSL | 276 | Q9Y585 | |
| TAQLTGVLLYYVPPV | 256 | Q8NGN2 | |
| YAVGTPSLNPLIYTL | 276 | O95918 | |
| EFVAPEVINYEPIGY | 1626 | Q15746 | |
| SYYPEASIPSSAIVG | 501 | P08235 | |
| SDGYPVLEYIPENVS | 571 | P08235 | |
| VYGTPETELTYPTNI | 801 | P78559 | |
| SSGAPVYVDLAYIPN | 2686 | P78559 | |
| TPYIIGVPASFFLYK | 371 | Q8WXG6 | |
| VDYYTTTPALVFGKP | 451 | P43243 | |
| LLQYTSYGVTPPSLS | 866 | Q14703 | |
| ILVQVPRASGSPDYY | 126 | Q6ZVW7 | |
| FETPVEAQYVRLYPT | 196 | Q08431 | |
| YIVSGTPTFVPYLIK | 806 | Q92823 | |
| VIEQYIGRFLPASPY | 1026 | Q6ZRQ5 | |
| LYYTDPPSVSAVNAV | 691 | Q8NDA2 | |
| SLQFIGSPYSLPYAV | 136 | P0C7T5 | |
| LFLTGVTFPSEYPIY | 91 | O15327 | |
| YVFLGPTPELVTQQY | 2111 | O43451 | |
| VPYGFLTVSTNPFVF | 166 | Q9Y231 | |
| LSATEGVPQVYYFGP | 96 | P78368 | |
| QEGPIIPYYVSVTTG | 1416 | Q8IVV2 | |
| TINGVPYTLSPTAYT | 326 | P14091 | |
| PYTLSPTAYTLLDFV | 331 | P14091 | |
| QGVRTYVDPFTYEDP | 591 | P54764 | |
| NSYGVPDDLLYSFPV | 276 | P40925 | |
| EFPIISPGRVYEYTS | 351 | Q9UK99 | |
| TFTVKYVPPAAGRYT | 806 | O75369 | |
| SVSYLPTKPGEYFVN | 1096 | O75369 | |
| YFPTVPGVYIVSTKF | 2061 | O75369 | |
| GYPVTNAVITVPAYF | 136 | P0DMV9 | |
| SGNTPVIQDYPLIYE | 356 | P17181 | |
| YFPGSIIDYPEEISV | 2231 | Q9Y6V0 | |
| PSYVVYGLKLFSPVF | 931 | A6NKB5 | |
| SSPGLIYTYTQDPTV | 1011 | P51805 | |
| QPSTGVPLVTGYTTY | 181 | Q02556 | |
| ITTNPYDYPFVSQGE | 306 | Q9UKX2 | |
| YPYFIGVSLGSIIVI | 431 | Q9UJA9 | |
| YLPTEPGEYTINILF | 1121 | Q14315 | |
| TVEYIPFTPGDYDVN | 1406 | Q14315 | |
| VSYLPTAPGDYSIIV | 1916 | Q14315 | |
| ASFPVYDLNITVYPV | 1006 | Q5H8C1 | |
| IYVITAFNLSYPITP | 16 | P48357 | |
| VVNFPPALYEYVTGE | 201 | P36915 | |
| IYPIAQIQEPYTAVG | 431 | P36915 | |
| TFPNHYSIVTGLYPE | 256 | P22413 | |
| RYPTPYGITVFENSI | 2276 | P98164 | |
| AFYGYEPTIPAVANS | 71 | Q7Z3K6 | |
| SYGTIFAVYLQPTSP | 251 | O60431 | |
| VFYTIGTPFLNPLIY | 271 | Q6IEV9 | |
| TYTFTYPNITLKDPQ | 136 | Q6IE36 | |
| EVYGTPGVDIYISPN | 41 | Q9ULW8 | |
| PPNAYTVTDLVEYSI | 321 | P39656 | |
| SFGYALVYTSPVIPA | 51 | Q9UGQ3 | |
| VTPAEPVQYYFTLAQ | 136 | Q13952 | |
| SSQYPFPVTLYVPNV | 161 | Q5R372 | |
| YIQPGPYVDPFTTVT | 566 | Q7Z442 | |
| YYFLSIQVPPSVAGA | 3236 | Q96RW7 | |
| FYQVTVPESIPVGYS | 2451 | Q6V1P9 | |
| FSQYGSPEFVSPEII | 6621 | Q5VST9 | |
| FLVQPDGVTLEYNPY | 101 | P10619 | |
| TGQVLYVPDPEYVSS | 136 | Q8N573 | |
| SSYPVALIPGQFQEY | 251 | Q8WUB8 | |
| TLTLEQKLFSGPYPY | 1011 | Q6PIJ6 | |
| ALRTPYYSVAQVGIP | 526 | Q86VX9 | |
| PLTVATTGPSVYYSQ | 866 | A6NKT7 | |
| YEGNSYTFIDPTQLP | 556 | P07333 | |
| PDNIFLTAPYYGSRI | 2276 | Q6WRI0 | |
| ALGAAYVYAIPTEIP | 11 | P05113 | |
| PDNPEFNIGYAITVY | 171 | Q13325 | |
| EYPTYPDSAFQVTTG | 521 | Q9NQZ3 | |
| RSPFQVTAGYQLPVY | 551 | Q9NQZ3 | |
| AYPSSPFQVTAGYQL | 596 | Q9NQZ3 | |
| SSPFQVTTGYQLPVY | 671 | Q9NQZ3 | |
| QKIFTTPLTPSQYYS | 146 | P49454 | |
| PNTIYEVSITAIYPD | 1716 | Q99715 | |
| FPNHYTIVTGLYPES | 206 | O14638 | |
| YVPTEPGDYNINILF | 1126 | P21333 | |
| YVPSREGPYSISVLY | 1511 | P21333 | |
| SVSYLPVLPGDYSIL | 1921 | P21333 | |
| APITGYRIVYSPSVE | 836 | P02751 | |
| SGLTPGVEYVYTIQV | 1141 | P02751 | |
| YAGLASVEPYVPEFT | 166 | Q6P158 | |
| GYYISPRITFPSLQA | 186 | P51451 | |
| TAAYVYVVNPTPFEG | 356 | H7C350 | |
| TVQLYGPTYFAPVIN | 396 | Q8IYJ1 | |
| SPVFVGLPYYAAVQV | 2081 | Q8TDW7 | |
| PPVFNQLIYESYVSE | 2391 | Q8TDW7 | |
| NPVDYTVQIPPSTTY | 351 | Q12906 | |
| VPVPGYFRLSQTYAT | 146 | P28358 | |
| VVDLGNEYPTPRSYT | 166 | A8MZ97 | |
| PKFIQVGVVQYSDYP | 71 | Q96P44 | |
| VGVVQYSDYPVLEIP | 76 | Q96P44 | |
| DPVPYSIINNYFSIG | 576 | Q9Y6T7 | |
| VPTPIYQTSSGQYIA | 156 | P16220 | |
| VILEPPNYGIVTEYA | 71 | Q9NYL2 | |
| SPCVAGVIPVIYYSV | 151 | Q7Z601 | |
| GTFIAPPVYSNITPY | 616 | Q6PJG2 | |
| NIIGVIPYFPYSKQS | 91 | Q14558 | |
| NLYPSGLPEEYSFLT | 101 | P20849 | |
| IAVPSSYSPTVALDY | 556 | Q13683 | |
| EYPTYPDSAFQVTTG | 356 | Q86SG3 | |
| RSPFQVTAGYQLPVY | 386 | Q86SG3 | |
| AYPSSPFQVTAGYQL | 431 | Q86SG3 | |
| SSPFQVTTGYQLPVY | 506 | Q86SG3 | |
| TEALNPSVYTYEVSP | 136 | Q6ZQY3 | |
| GYPVTNAVITVPAYF | 136 | P0DMV8 | |
| VYSILEGQPYFSIEP | 206 | P55286 | |
| SVYYLPIFIVDSGSP | 556 | Q9ULB5 | |
| GVPYFYLSPLQLSVS | 101 | O75629 | |
| QVGYVPEKYLQFPTS | 516 | O94868 | |
| EPADSGQSLVPVYIY | 6 | Q9BY41 | |
| YSEAAITIRGTYFPP | 961 | Q7L014 | |
| VTTGQYYLVDTPVQP | 1616 | D6RIA3 | |
| PTYDEIFYTLSPVNG | 446 | Q9H4M9 | |
| LPRIFPSVTSYYSGE | 241 | Q9UQ72 | |
| SPGVPYYLQTFVSEI | 76 | Q9H4I8 | |
| VRPFDGNSPILYYIV | 691 | Q7Z5N4 | |
| FPYGSTQDYLNPIIL | 2131 | Q9NZJ4 | |
| FYLPYEGEISPTNTN | 1166 | Q8IZU8 | |
| YFPAGRYVVVAESPL | 516 | Q3KP66 | |
| SYLFDPVQVPSPGYV | 11 | Q8IY42 | |
| YPTKTFPNLYTLATG | 206 | Q13822 | |
| FPNLYTLATGLYPES | 211 | Q13822 | |
| PLSTLTVYYSPETIG | 671 | P20273 | |
| VPTDYSYLPESSFIG | 1351 | Q5VW36 | |
| YIQSLPAYDSPEVFG | 4301 | Q8TE73 | |
| NYSYELVLPSTNPGT | 711 | Q9BZA8 | |
| GNIYPPLITIAYSDI | 481 | Q5HYA8 | |
| YAVGTPSLNPLVYTL | 276 | Q9GZK4 | |
| TVYTDFDGTRVYSPP | 196 | P11309 | |
| SPGVPYYLQTFVSEI | 76 | Q9NQF3 | |
| APPYPDVNTFDITVY | 1281 | P08581 | |
| VNLTVYYPPEVSISG | 236 | P15151 | |
| QAVLSYIFPTYGVTP | 256 | Q6NUM9 | |
| PVVIDYTPYLKFTQS | 196 | Q59EK9 | |
| YQYFTKTVFLSGLPP | 106 | Q9NP92 | |
| VPQFSGLVQPYEDVY | 161 | P78337 | |
| PLTVATTGPSVYYSQ | 866 | Q7Z3J3 | |
| LNPVVGAVYSPEFYA | 211 | Q9NWB1 | |
| ALAETGIAVPSYYNP | 306 | Q7L4I2 | |
| VVVPYQGPSSDYVVV | 1911 | Q92673 | |
| VYTPEVYPTATRALG | 446 | Q8N4V2 | |
| SSTVPIPTVNQYLYF | 286 | P35610 | |
| YSTVGTPDYIAPEVF | 281 | Q9Y2H1 | |
| APTFYVSDVENYVGP | 141 | O75151 | |
| VLAVLDSAVTPGPYY | 266 | Q8NHS9 | |
| YIAVTDPLVYPTKFT | 131 | Q96RI8 | |
| FDRGYYEVTPPTLVQ | 261 | O43776 | |
| VDQPEGTPVELYYTV | 216 | Q14C87 | |
| NSIYIRPYITTPGGT | 211 | Q9NYJ8 | |
| PFSVNPVYITYTQPT | 421 | Q8N5C8 | |
| SSTPYSPVIYDGNIY | 546 | A0AVI2 | |
| VPSPYEVRGFPTIYF | 441 | P30101 | |
| STSYGVIIIQVPVGY | 86 | Q14916 | |
| NTFPLGYYLIPFTGI | 166 | Q9H6Y7 | |
| LAYIPTPIYFGAVID | 696 | Q9H2Y9 | |
| IQTLPSEYDTPLYFE | 176 | Q86TU7 | |
| SAATYYPFVQEPPVT | 46 | Q96T21 | |
| TNPYDYPFISQGEIL | 306 | P11055 | |
| YELAVGTPPFYATSI | 191 | Q9NRP7 | |
| DGVVPATVNYYVTPV | 396 | Q96A09 | |
| TVPVVYPDGTEQYFG | 646 | Q86VW0 | |
| IVAALGETFLPYYTG | 196 | Q9NP78 | |
| RPQGSSPVYEYTTEA | 51 | Q8IVF2 | |
| PGSSEIPAYTSAYLI | 51 | Q0P6D6 | |
| SVPTPIYQTSSGQYI | 96 | P18846 | |
| VASLSFYTPEIPGRY | 2141 | Q8N3C0 | |
| YKTPQPIGEVYFAET | 51 | O14967 | |
| ISNPYQTFLGPTGVY | 116 | Q8NCR9 | |
| TYSPNTAYGVDFLVP | 781 | Q9ULV3 | |
| VVSYTTNGYPTEYIP | 66 | Q7L0Q8 | |
| IIDTTYPAYVGPQEV | 266 | Q12884 | |
| DYENVPTTVFTPLEY | 516 | Q16881 | |
| TEYIPDPERVFYTGQ | 576 | Q14690 | |
| YTYILEVFGPLPAFV | 111 | Q9UPY5 | |
| YPSVENVRTSLEGYP | 441 | Q9NUW8 | |
| EYVTEPIQAYIIPSG | 21 | Q9NQW7 | |
| PAYVSPEILNTTGTY | 246 | Q96RU8 | |
| SANPPVVSTVYAYIG | 1236 | Q8IZQ1 | |
| VVSTVYAYIGTPPAQ | 1241 | Q8IZQ1 | |
| PSSNVTTIYELGPNY | 1276 | Q8IZQ1 | |
| QPSYDLSTVLPGLTY | 546 | Q9NXZ1 | |
| GEGYFIVTPQTYFIT | 181 | Q6ZVD7 | |
| PTPDGYFIVTPQTYF | 131 | Q9P2F5 | |
| PPSVEVEYYTIAEFQ | 446 | Q5TCZ1 | |
| PAYVSPEILNTSGSY | 216 | Q92519 | |
| TYRQGYDVSIPVYSP | 221 | Q93063 | |
| YDVSIPVYSPLSAEV | 226 | Q93063 | |
| VTYIAPPGNYDTSDV | 176 | P38606 | |
| SEYNYAPPVVKFITI | 61 | Q5VVX9 | |
| LYPVLVIDSSGYVNP | 171 | P01833 | |
| AELNSYVPVTAYTGP | 136 | P22314 | |
| YVPVTAYTGPLVEDF | 141 | P22314 | |
| TYAPYVTFPVAFVVG | 11 | Q96EX1 | |
| QFSEPVGIIYNPVEY | 46 | Q53HV7 | |
| PQAIVYPFIISSESY | 3526 | P78527 | |
| TSGYPPTLVYQNGSI | 221 | Q9Y6W5 | |
| GSYREINPAPYTIIT | 386 | Q9HBG4 | |
| YVLRPSYNGSFVTPD | 161 | Q9NS56 | |
| YINVPTTVFTPLEYG | 511 | Q86VQ6 | |
| YPGSYLTFEVVSFVP | 581 | O43895 | |
| LYVGPGVSEFIQPYL | 211 | Q64LD2 | |
| ATPGYFPTVVQPYVE | 986 | Q9H4A3 | |
| PPLYVLFVQATAYGQ | 266 | Q13769 | |
| TTVQLTIYYPPEGQP | 321 | P0DP72 | |
| GPFTLILQSYPDNSY | 491 | Q05996 | |
| TVYYVITHLVPQSFP | 486 | Q9H091 | |
| YPAPERLQEYGSIFT | 76 | Q9NQA3 | |
| LGTYITVEEIIYPTP | 466 | Q6YBV0 | |
| LHSYYDPFVLSVQPV | 316 | Q8IU80 | |
| DPPTLDQIVSYVYTG | 81 | Q2WGJ6 | |
| AFVAPAPPVETTYNY | 356 | Q5VV43 | |
| YNELTEIPYFGEPTS | 106 | O94898 |